"diseaseId","diseaseName","drugId","drugName","type","mechanismOfAction","actionType","symbol","name","phase","status","source"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04512079%22,https://clinicaltrials.gov/search?id=%22NCT04406389%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB3","gamma-aminobutyric acid type A receptor subunit beta3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRP","gamma-aminobutyric acid type A receptor subunit pi",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04291729%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04286503%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB2","gamma-aminobutyric acid type A receptor subunit beta2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04316377%22"
"MONDO_0100096","COVID-19","CHEMBL1201561","PEGINTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04254874%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB1","gamma-aminobutyric acid type A receptor subunit beta1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL237500","LINAGLIPTIN","Small molecule","Dipeptidyl peptidase IV inhibitor","Inhibitor","DPP4","dipeptidyl peptidase 4",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04341935%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA1","gamma-aminobutyric acid type A receptor subunit alpha1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04834375%22,https://clinicaltrials.gov/search?id=%22NCT04530409%22,https://clinicaltrials.gov/search?id=%22NCT04780581%22,https://clinicaltrials.gov/search?id=%22NCT04528329%22,https://clinicaltrials.gov/search?id=%22NCT04663555%22,https://clinicaltrials.gov/search?id=%22NCT04707534%22,https://clinicaltrials.gov/search?id=%22NCT04726098%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA5","gamma-aminobutyric acid type A receptor subunit alpha5",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04836806%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04316377%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL1069","VALSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04335786%22"
"MONDO_0100096","COVID-19","CHEMBL501259","ERITORAN","Small molecule","Toll-like receptor 4/MD-2 antagonist","Antagonist","LY96","lymphocyte antigen 96",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04286503%22"
"MONDO_0100096","COVID-19","CHEMBL650","METHYLPREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04780581%22,https://clinicaltrials.gov/search?id=%22NCT04263402%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04286503%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA1","gamma-aminobutyric acid type A receptor subunit alpha1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL778","DEXMEDETOMIDINE","Small molecule","Adrenergic receptor alpha-2 agonist","Agonist","ADRA2B","adrenoceptor alpha 2B",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04350086%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04291729%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARA","retinoic acid receptor alpha",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04623385%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRD","gamma-aminobutyric acid type A receptor subunit delta",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA5","gamma-aminobutyric acid type A receptor subunit alpha5",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350684%22,https://clinicaltrials.gov/search?id=%22NCT04350671%22"
"MONDO_0100096","COVID-19","CHEMBL779","TADALAFIL","Small molecule","Phosphodiesterase 5A inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04946162%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA2","gamma-aminobutyric acid type A receptor subunit alpha2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA3","gamma-aminobutyric acid type A receptor subunit alpha3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA6","gamma-aminobutyric acid type A receptor subunit alpha6",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA2","gamma-aminobutyric acid type A receptor subunit alpha2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1201772","PRASUGREL","Small molecule","Purinergic receptor P2Y12 antagonist","Antagonist","P2RY12","purinergic receptor P2Y12",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Glycine receptor (alpha-1/beta) positive modulator","Positive modulator","GLRA1","glycine receptor alpha 1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 9 opener","Opener","KCNK9","potassium two pore domain channel subfamily K member 9",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350684%22,https://clinicaltrials.gov/search?id=%22NCT04350671%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG1","gamma-aminobutyric acid type A receptor subunit gamma1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4B","phosphodiesterase 4B",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA3","gamma-aminobutyric acid type A receptor subunit alpha3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 10 opener","Opener","KCNK10","potassium two pore domain channel subfamily K member 10",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04738045%22,https://clinicaltrials.gov/search?id=%22NCT04345276%22,https://clinicaltrials.gov/search?id=%22NCT04255017%22,https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 18 opener","Opener","KCNK18","potassium two pore domain channel subfamily K member 18",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04338906%22,https://clinicaltrials.gov/search?id=%22NCT04351919%22"
"MONDO_0100096","COVID-19","CHEMBL1201561","PEGINTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04254874%22"
"MONDO_0100096","COVID-19","CHEMBL848","LENALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","DDB1","damage specific DNA binding protein 1",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04361643%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04351191%22,https://clinicaltrials.gov/search?id=%22NCT04346667%22,https://clinicaltrials.gov/search?id=%22NCT04341493%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04291729%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04394377%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04316377%22"
"MONDO_0100096","COVID-19","CHEMBL1536","ERGOCALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04411446%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04520620%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350671%22,https://clinicaltrials.gov/search?id=%22NCT04350684%22"
"MONDO_0100096","COVID-19","CHEMBL1017","TELMISARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355936%22"
"MONDO_0100096","COVID-19","CHEMBL778","DEXMEDETOMIDINE","Small molecule","Adrenergic receptor alpha-2 agonist","Agonist","ADRA2C","adrenoceptor alpha 2C",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04350086%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG2","gamma-aminobutyric acid type A receptor subunit gamma2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL521","IBUPROFEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04334629%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARB","retinoic acid receptor beta",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04623385%22"
"MONDO_0100096","COVID-19","CHEMBL1042","CHOLECALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04552951%22,https://clinicaltrials.gov/search?id=%22NCT04636086%22"
"MONDO_0100096","COVID-19","CHEMBL198362","RIVAROXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04394377%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04359316%22,https://clinicaltrials.gov/search?id=%22NCT04359615%22,https://clinicaltrials.gov/search?id=%22NCT04363203%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4C","phosphodiesterase 4C",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 3 opener","Opener","KCNK3","potassium two pore domain channel subfamily K member 3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04325061%22,https://clinicaltrials.gov/search?id=%22NCT04746430%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04565392%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04466540%22,https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04355026%22,https://clinicaltrials.gov/search?id=%22NCT02735707%22,https://clinicaltrials.gov/search?id=%22NCT04362332%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04729140%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350684%22,https://clinicaltrials.gov/search?id=%22NCT04350671%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04360824%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRE","gamma-aminobutyric acid type A receptor subunit epsilon",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04729140%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22,https://clinicaltrials.gov/search?id=%22NCT04255017%22,https://clinicaltrials.gov/search?id=%22NCT04345276%22,https://clinicaltrials.gov/search?id=%22NCT04738045%22"
"MONDO_0100096","COVID-19","CHEMBL1064","SIMVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1201670","SARGRAMOSTIM","Protein","Granulocyte-macrophage colony-stimulating factor receptor agonist","Agonist","CSF2RA","colony stimulating factor 2 receptor subunit alpha",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04326920%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRE","gamma-aminobutyric acid type A receptor subunit epsilon",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04351919%22,https://clinicaltrials.gov/search?id=%22NCT04338906%22"
"MONDO_0100096","COVID-19","CHEMBL848","LENALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","CUL4A","cullin 4A",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04361643%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA6","gamma-aminobutyric acid type A receptor subunit alpha6",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRQ","gamma-aminobutyric acid type A receptor subunit theta",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB2","gamma-aminobutyric acid type A receptor subunit beta2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1000","CETIRIZINE","Small molecule","Histamine H1 receptor antagonist","Antagonist","HRH1","histamine receptor H1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04836806%22"
"MONDO_0100096","COVID-19","CHEMBL1166","ARGATROBAN","Small molecule","Thrombin inhibitor","Inhibitor","F2","coagulation factor II, thrombin",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04406389%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04351191%22,https://clinicaltrials.gov/search?id=%22NCT04341493%22,https://clinicaltrials.gov/search?id=%22NCT04346667%22"
"MONDO_0100096","COVID-19","CHEMBL231779","APIXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04512079%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG1","gamma-aminobutyric acid type A receptor subunit gamma1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04291729%22"
"MONDO_0100096","COVID-19","CHEMBL1370","BUDESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04355637%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350684%22,https://clinicaltrials.gov/search?id=%22NCT04350671%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04730323%22"
"MONDO_0100096","COVID-19","CHEMBL521","IBUPROFEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04334629%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4D","phosphodiesterase 4D",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1042","CHOLECALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04952857%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04729140%22,https://clinicaltrials.gov/search?id=%22NCT04715295%22"
"MONDO_0100096","COVID-19","CHEMBL160","CYCLOSPORINE","Protein","Cyclophilin A modulator","Modulator","PPIA","peptidylprolyl isomerase A",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04392531%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL501259","ERITORAN","Small molecule","Toll-like receptor 4/MD-2 antagonist","Antagonist","TLR4","toll like receptor 4",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04729140%22,https://clinicaltrials.gov/search?id=%22NCT04715295%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04394377%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRD","gamma-aminobutyric acid type A receptor subunit delta",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA4","gamma-aminobutyric acid type A receptor subunit alpha4",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04584580%22,https://clinicaltrials.gov/search?id=%22NCT04505774%22,https://clinicaltrials.gov/search?id=%22NCT04406389%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04286503%22"
"MONDO_0100096","COVID-19","CHEMBL1771","CLOPIDOGREL","Small molecule","Purinergic receptor P2Y12 antagonist","Antagonist","P2RY12","purinergic receptor P2Y12",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04334967%22"
"MONDO_0100096","COVID-19","CHEMBL2108730","SARILUMAB","Antibody","Interleukin-6 receptor alpha subunit antagonist","Antagonist","IL6R","interleukin 6 receptor",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARG","retinoic acid receptor gamma",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04623385%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB1","gamma-aminobutyric acid type A receptor subunit beta1",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG3","gamma-aminobutyric acid type A receptor subunit gamma3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1201621","SOMATROPIN","Protein","Growth hormone receptor agonist","Agonist","GHR","growth hormone receptor",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04532554%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG3","gamma-aminobutyric acid type A receptor subunit gamma3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL778","DEXMEDETOMIDINE","Small molecule","Adrenergic receptor alpha-2 agonist","Agonist","ADRA2A","adrenoceptor alpha 2A",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04350086%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04334967%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04363203%22,https://clinicaltrials.gov/search?id=%22NCT04359615%22,https://clinicaltrials.gov/search?id=%22NCT04359316%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350671%22,https://clinicaltrials.gov/search?id=%22NCT04350684%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRQ","gamma-aminobutyric acid type A receptor subunit theta",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04255017%22,https://clinicaltrials.gov/search?id=%22NCT04345276%22,https://clinicaltrials.gov/search?id=%22NCT04738045%22,https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04729140%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04729140%22,https://clinicaltrials.gov/search?id=%22NCT04715295%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04729140%22"
"MONDO_0100096","COVID-19","CHEMBL1616951","CANRENOATE","Small molecule","Mineralocorticoid receptor antagonist","Antagonist","NR3C2","nuclear receptor subfamily 3 group C member 2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04912011%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350671%22,https://clinicaltrials.gov/search?id=%22NCT04350684%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04351191%22,https://clinicaltrials.gov/search?id=%22NCT04346667%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04652648%22,https://clinicaltrials.gov/search?id=%22NCT04370782%22,https://clinicaltrials.gov/search?id=%22NCT04746365%22"
"MONDO_0100096","COVID-19","CHEMBL848","LENALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","CRBN","cereblon",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04361643%22"
"MONDO_0100096","COVID-19","CHEMBL1201631","INSULIN","Protein","Insulin receptor agonist","Agonist","INSR","insulin receptor",4,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04341935%22"
"MONDO_0100096","COVID-19","CHEMBL386630","TESTOSTERONE","Small molecule","Androgen Receptor agonist","Agonist","AR","androgen receptor",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04623385%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04350671%22,https://clinicaltrials.gov/search?id=%22NCT04350684%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 2 opener","Opener","KCNK2","potassium two pore domain channel subfamily K member 2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370782%22"
"MONDO_0100096","COVID-19","CHEMBL1371200","CANRENOATE POTASSIUM","Small molecule","Mineralocorticoid receptor antagonist","Antagonist","NR3C2","nuclear receptor subfamily 3 group C member 2",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04912011%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04351191%22,https://clinicaltrials.gov/search?id=%22NCT04346667%22"
"MONDO_0100096","COVID-19","CHEMBL198362","RIVAROXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04757857%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04355026%22,https://clinicaltrials.gov/search?id=%22NCT04362332%22,https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04466540%22,https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL389621","HYDROCORTISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB3","gamma-aminobutyric acid type A receptor subunit beta3",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04316377%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA4","gamma-aminobutyric acid type A receptor subunit alpha4",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG2","gamma-aminobutyric acid type A receptor subunit gamma2",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL635","PREDNISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04534478%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",4,"Completed","https://clinicaltrials.gov/search?id=%22NCT04652648%22,https://clinicaltrials.gov/search?id=%22NCT04370782%22,https://clinicaltrials.gov/search?id=%22NCT04746365%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4A","phosphodiesterase 4A",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL526","PROPOFOL","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRP","gamma-aminobutyric acid type A receptor subunit pi",4,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359862%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04255017%22,https://clinicaltrials.gov/search?id=%22NCT04738045%22,https://clinicaltrials.gov/search?id=%22NCT02735707%22,https://clinicaltrials.gov/search?id=%22NCT04345276%22"
"MONDO_0100096","COVID-19","CHEMBL398435","TICAGRELOR","Small molecule","Purinergic receptor P2Y12 negative allosteric modulator","Negative allosteric modulator","P2RY12","purinergic receptor P2Y12",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT02735707%22"
"MONDO_0100096","COVID-19","CHEMBL848","LENALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","RBX1","ring-box 1",4,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04361643%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",4,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04715295%22,https://clinicaltrials.gov/search?id=%22NCT04729140%22"
"MONDO_0100096","COVID-19","CHEMBL707","DOXAZOSIN","Small molecule","Adrenergic receptor alpha-1 antagonist","Antagonist","ADRA1D","adrenoceptor alpha 1D",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04364022%22"
"MONDO_0100096","COVID-19","CHEMBL2108677","PEGINTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04403685%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04410328%22,https://clinicaltrials.gov/search?id=%22NCT04483960%22"
"MONDO_0100096","COVID-19","CHEMBL3545189","LANADELUMAB","Antibody","Plasma kallikrein inhibitor","Inhibitor","KLKB1","kallikrein B1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04590586%22"
"MONDO_0100096","COVID-19","CHEMBL814","FLUVOXAMINE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22,https://clinicaltrials.gov/search?id=%22NCT04885530%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2C","glutamate ionotropic receptor NMDA type subunit 2C",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRD","gamma-aminobutyric acid type A receptor subunit delta",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL2108677","PEGINTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL1201580","ADALIMUMAB","Antibody","TNF-alpha inhibitor","Inhibitor","TNF","tumor necrosis factor",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04705844%22"
"MONDO_0100096","COVID-19","CHEMBL434394","NEBIVOLOL","Small molecule","Beta-1 adrenergic receptor antagonist","Antagonist","ADRB1","adrenoceptor beta 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04631536%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG2","gamma-aminobutyric acid type A receptor subunit gamma2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN1","glutamate ionotropic receptor NMDA type subunit 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA2B","adrenoceptor alpha 2B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04843761%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2D","glutamate ionotropic receptor NMDA type subunit 2D",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04952519%22,https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04832880%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR4","fibroblast growth factor receptor 4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL2109343","LERONLIMAB","Antibody","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04901676%22,https://clinicaltrials.gov/search?id=%22NCT04901689%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRQ","gamma-aminobutyric acid type A receptor subunit theta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA1D","adrenoceptor alpha 1D",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04843761%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04832880%22"
"MONDO_0100096","COVID-19","CHEMBL429910","DAPAGLIFLOZIN","Small molecule","Sodium/glucose cotransporter 2 inhibitor","Inhibitor","SLC5A2","solute carrier family 5 member 2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04350593%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04328285%22,https://clinicaltrials.gov/search?id=%22NCT04315948%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRP","gamma-aminobutyric acid type A receptor subunit pi",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA2","gamma-aminobutyric acid type A receptor subunit alpha2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR1","fibroblast growth factor receptor 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 3 opener","Opener","KCNK3","potassium two pore domain channel subfamily K member 3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04365582%22,https://clinicaltrials.gov/search?id=%22NCT04409483%22"
"MONDO_0100096","COVID-19","CHEMBL3544984","TRADIPITANT","Small molecule","Neurokinin 1 receptor antagonist","Antagonist","TACR1","tachykinin receptor 1",3,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04326426%22"
"MONDO_0100096","COVID-19","CHEMBL3707348","ACALABRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04647669%22"
"MONDO_0100096","COVID-19","CHEMBL1201265","METHYLPREDNISOLONE HEMISUCCINATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04826588%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22,https://clinicaltrials.gov/search?id=%22NCT04328480%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04359277%22"
"MONDO_0100096","COVID-19","CHEMBL4297717","CD24FC","Unknown","Heat shock 70 kDa protein 1A/1B inhibitor","Inhibitor","HSPA1A","heat shock protein family A (Hsp70) member 1A",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04317040%22"
"MONDO_0100096","COVID-19","CHEMBL3","NICOTINE","Small molecule","Neuronal acetylcholine receptor; alpha4/beta2 agonist","Agonist","CHRNA4","cholinergic receptor nicotinic alpha 4 subunit",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04608201%22,https://clinicaltrials.gov/search?id=%22NCT04583410%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","D2-like dopamine receptor antagonist","Antagonist","DRD4","dopamine receptor D4",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04366739%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04401579%22,https://clinicaltrials.gov/search?id=%22NCT04421027%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA6","gamma-aminobutyric acid type A receptor subunit alpha6",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB3","gamma-aminobutyric acid type A receptor subunit beta3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA1","gamma-aminobutyric acid type A receptor subunit alpha1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 2 opener","Opener","KCNK2","potassium two pore domain channel subfamily K member 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7B","phosphodiesterase 7B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04409483%22,https://clinicaltrials.gov/search?id=%22NCT04365582%22"
"MONDO_0100096","COVID-19","CHEMBL2095208","COBICISTAT","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04252274%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04341727%22"
"MONDO_0100096","COVID-19","CHEMBL3","NICOTINE","Small molecule","Neuronal acetylcholine receptor; alpha4/beta2 agonist","Agonist","CHRNB2","cholinergic receptor nicotinic beta 2 subunit",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04583410%22,https://clinicaltrials.gov/search?id=%22NCT04608201%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB3","gamma-aminobutyric acid type A receptor subunit beta3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04640168%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB3","gamma-aminobutyric acid type A receptor subunit beta3",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04647669%22"
"MONDO_0100096","COVID-19","CHEMBL2108806","BEMIPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04604327%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL1743033","ITOLIZUMAB","Antibody","T-cell differentiation antigen CD6 inhibitor","Inhibitor","CD6","CD6 molecule",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04605926%22"
"MONDO_0100096","COVID-19","CHEMBL1536","ERGOCALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04372017%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04315948%22,https://clinicaltrials.gov/search?id=%22NCT04328285%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04364022%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN3B","glutamate ionotropic receptor NMDA type subunit 3B",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL4297717","CD24FC","Unknown","Sialic acid-binding Ig-like lectin 10 modulator","Modulator","SIGLEC10","sialic acid binding Ig like lectin 10",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04317040%22"
"MONDO_0100096","COVID-19","CHEMBL4297717","CD24FC","Unknown","High mobility group protein B1 inhibitor","Inhibitor","HMGB1","high mobility group box 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04317040%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB1","gamma-aminobutyric acid type A receptor subunit beta1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2B","glutamate ionotropic receptor NMDA type subunit 2B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04952519%22,https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL23","DILTIAZEM","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1F","calcium voltage-gated channel subunit alpha1 F",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04372082%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4A","phosphodiesterase 4A",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04590586%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG3","gamma-aminobutyric acid type A receptor subunit gamma3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3B","phosphodiesterase 3B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA2","gamma-aminobutyric acid type A receptor subunit alpha2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1201581","INFLIXIMAB","Antibody","TNF-alpha inhibitor","Inhibitor","TNF","tumor necrosis factor",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04593940%22"
"MONDO_0100096","COVID-19","CHEMBL3","NICOTINE","Small molecule","Neuronal acetylcholine receptor; alpha4/beta2 agonist","Agonist","CHRNB2","cholinergic receptor nicotinic beta 2 subunit",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04598594%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04321174%22,https://clinicaltrials.gov/search?id=%22NCT04261270%22,https://clinicaltrials.gov/search?id=%22NCT04303299%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2A","glutamate ionotropic receptor NMDA type subunit 2A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22,https://clinicaltrials.gov/search?id=%22NCT04952519%22"
"MONDO_0100096","COVID-19","CHEMBL198362","RIVAROXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04508023%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6A","phosphodiesterase 6A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR2","fibroblast growth factor receptor 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL650","METHYLPREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04345445%22,https://clinicaltrials.gov/search?id=%22NCT04673162%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4D","phosphodiesterase 4D",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04590586%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL1201414","TINZAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04483960%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2A","glutamate ionotropic receptor NMDA type subunit 2A",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 18 opener","Opener","KCNK18","potassium two pore domain channel subfamily K member 18",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1201438","ALDESLEUKIN","Protein","Interleukin-2 receptor agonist","Agonist","IL2RA","interleukin 2 receptor subunit alpha",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04724629%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22"
"MONDO_0100096","COVID-19","CHEMBL231779","APIXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04650087%22,https://clinicaltrials.gov/search?id=%22NCT04801940%22"
"MONDO_0100096","COVID-19","CHEMBL1064","SIMVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04343001%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Anandamide amidohydrolase inhibitor","Inhibitor","FAAH","fatty acid amide hydrolase",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04536051%22,https://clinicaltrials.gov/search?id=%22NCT04673214%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE2A","phosphodiesterase 2A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRE","gamma-aminobutyric acid type A receptor subunit epsilon",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04498273%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391127%22,https://clinicaltrials.gov/search?id=%22NCT04321278%22,https://clinicaltrials.gov/search?id=%22NCT04261517%22,https://clinicaltrials.gov/search?id=%22NCT04308668%22,https://clinicaltrials.gov/search?id=%22NCT04332991%22,https://clinicaltrials.gov/search?id=%22NCT04331834%22,https://clinicaltrials.gov/search?id=%22NCT04420247%22,https://clinicaltrials.gov/search?id=%22NCT04334148%22,https://clinicaltrials.gov/search?id=%22NCT04328467%22,https://clinicaltrials.gov/search?id=%22NCT04446104%22,https://clinicaltrials.gov/search?id=%22NCT04358081%22"
"MONDO_0100096","COVID-19","CHEMBL1496","ROSUVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04472611%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04342221%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04321174%22,https://clinicaltrials.gov/search?id=%22NCT04303299%22,https://clinicaltrials.gov/search?id=%22NCT04261270%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA2C","adrenoceptor alpha 2C",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04843761%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IL10RB","interleukin 10 receptor subunit beta",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04967430%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04640168%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4D","phosphodiesterase 4D",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Glycine receptor (alpha-1/beta) positive modulator","Positive modulator","GLRA1","glycine receptor alpha 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL1269025","EDOXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04542408%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN3B","glutamate ionotropic receptor NMDA type subunit 3B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04315948%22,https://clinicaltrials.gov/search?id=%22NCT04328285%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04401293%22,https://clinicaltrials.gov/search?id=%22NCT04366960%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04485429%22,https://clinicaltrials.gov/search?id=%22NCT04542408%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL389621","HYDROCORTISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04348305%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6C","phosphodiesterase 6C",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN3A","glutamate ionotropic receptor NMDA type subunit 3A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","Potassium channel subfamily K member 18 opener","Opener","KCNK18","potassium two pore domain channel subfamily K member 18",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL4297717","CD24FC","Unknown","Heat shock 70 kDa protein 1A/1B inhibitor","Inhibitor","HSPA1B","heat shock protein family A (Hsp70) member 1B",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04317040%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Glycine receptor (alpha-1/beta) positive modulator","Positive modulator","GLRA1","glycine receptor alpha 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1370","BUDESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04331054%22,https://clinicaltrials.gov/search?id=%22NCT04361474%22"
"MONDO_0100096","COVID-19","CHEMBL1088752","LOSMAPIMOD","Small molecule","MAP kinase p38 alpha inhibitor","Inhibitor","MAPK14","mitogen-activated protein kinase 14",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04511819%22"
"MONDO_0100096","COVID-19","CHEMBL635","PREDNISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04795583%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2A","glutamate ionotropic receptor NMDA type subunit 2A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL3707325","LENZILUMAB","Antibody","Granulocyte-macrophage colony-stimulating factor inhibitor","Inhibitor","CSF2","colony stimulating factor 2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04351152%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN1","glutamate ionotropic receptor NMDA type subunit 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04952519%22,https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04345692%22,https://clinicaltrials.gov/search?id=%22NCT04522466%22,https://clinicaltrials.gov/search?id=%22NCT04325893%22,https://clinicaltrials.gov/search?id=%22NCT04329611%22,https://clinicaltrials.gov/search?id=%22NCT04342221%22,https://clinicaltrials.gov/search?id=%22NCT04374942%22,https://clinicaltrials.gov/search?id=%22NCT04341441%22,https://clinicaltrials.gov/search?id=%22NCT04421664%22,https://clinicaltrials.gov/search?id=%22NCT04339816%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","D2-like dopamine receptor antagonist","Antagonist","DRD3","dopamine receptor D3",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04366739%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA4","gamma-aminobutyric acid type A receptor subunit alpha4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL2095208","COBICISTAT","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04252274%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","Glycine receptor (alpha-1/beta) positive modulator","Positive modulator","GLRA1","glycine receptor alpha 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04370262%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR3","fibroblast growth factor receptor 3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL578","ENALAPRIL","Small molecule","Angiotensin-converting enzyme inhibitor","Inhibitor","ACE","angiotensin I converting enzyme",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04345406%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04516941%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04673214%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04536051%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG2","gamma-aminobutyric acid type A receptor subunit gamma2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Vascular endothelial growth factor receptor inhibitor","Inhibitor","KDR","kinase insert domain receptor",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22,https://clinicaltrials.gov/search?id=%22NCT04350320%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04554433%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6D","phosphodiesterase 6D",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04693026%22,https://clinicaltrials.gov/search?id=%22NCT04970719%22,https://clinicaltrials.gov/search?id=%22NCT04890626%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04970719%22,https://clinicaltrials.gov/search?id=%22NCT04909918%22,https://clinicaltrials.gov/search?id=%22NCT04765371%22,https://clinicaltrials.gov/search?id=%22NCT04784559%22,https://clinicaltrials.gov/search?id=%22NCT04890626%22,https://clinicaltrials.gov/search?id=%22NCT04347980%22,https://clinicaltrials.gov/search?id=%22NCT04499313%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04315948%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB2","gamma-aminobutyric acid type A receptor subunit beta2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04315948%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7A","phosphodiesterase 7A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04327401%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04362137%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA6","gamma-aminobutyric acid type A receptor subunit alpha6",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","Potassium channel subfamily K member 2 opener","Opener","KCNK2","potassium two pore domain channel subfamily K member 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA6","gamma-aminobutyric acid type A receptor subunit alpha6",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRD","gamma-aminobutyric acid type A receptor subunit delta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6B","phosphodiesterase 6B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04342156%22,https://clinicaltrials.gov/search?id=%22NCT04361461%22"
"MONDO_0100096","COVID-19","CHEMBL1017","TELMISARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04359953%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRQ","gamma-aminobutyric acid type A receptor subunit theta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRE","gamma-aminobutyric acid type A receptor subunit epsilon",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2B","glutamate ionotropic receptor NMDA type subunit 2B",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL237500","LINAGLIPTIN","Small molecule","Dipeptidyl peptidase IV inhibitor","Inhibitor","DPP4","dipeptidyl peptidase 4",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04371978%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL1536","ERGOCALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04536298%22,https://clinicaltrials.gov/search?id=%22NCT04621058%22,https://clinicaltrials.gov/search?id=%22NCT04641195%22"
"MONDO_0100096","COVID-19","CHEMBL23","DILTIAZEM","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1S","calcium voltage-gated channel subunit alpha1 S",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04372082%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1B","phosphodiesterase 1B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2C","glutamate ionotropic receptor NMDA type subunit 2C",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA1B","adrenoceptor alpha 1B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04843761%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 9 opener","Opener","KCNK9","potassium two pore domain channel subfamily K member 9",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL707","DOXAZOSIN","Small molecule","Adrenergic receptor alpha-1 antagonist","Antagonist","ADRA1A","adrenoceptor alpha 1A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL393220","ATORVASTATIN CALCIUM","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04486508%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8A","phosphodiesterase 8A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL707","DOXAZOSIN","Small molecule","Adrenergic receptor alpha-1 antagonist","Antagonist","ADRA1B","adrenoceptor alpha 1B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA1","gamma-aminobutyric acid type A receptor subunit alpha1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA2","gamma-aminobutyric acid type A receptor subunit alpha2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04732949%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN3A","glutamate ionotropic receptor NMDA type subunit 3A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22,https://clinicaltrials.gov/search?id=%22NCT04952519%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 18 opener","Opener","KCNK18","potassium two pore domain channel subfamily K member 18",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","Potassium channel subfamily K member 9 opener","Opener","KCNK9","potassium two pore domain channel subfamily K member 9",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","Equilibrative nucleoside transporter 1 inhibitor","Inhibitor","SLC29A1","solute carrier family 29 member 1 (Augustine blood group)",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARB","retinoic acid receptor beta",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04361422%22,https://clinicaltrials.gov/search?id=%22NCT04353180%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN3A","glutamate ionotropic receptor NMDA type subunit 3A",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA4","gamma-aminobutyric acid type A receptor subunit alpha4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1201460","DALTEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04483960%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Vascular endothelial growth factor receptor inhibitor","Inhibitor","FLT4","fms related receptor tyrosine kinase 4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IFNLR1","interferon lambda receptor 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04967430%22"
"MONDO_0100096","COVID-19","CHEMBL1737","SILDENAFIL CITRATE","Small molecule","Phosphodiesterase 5A inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04304313%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA1A","adrenoceptor alpha 1A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04843761%22"
"MONDO_0100096","COVID-19","CHEMBL3","NICOTINE","Small molecule","Neuronal acetylcholine receptor; alpha4/beta2 agonist","Agonist","CHRNA4","cholinergic receptor nicotinic alpha 4 subunit",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04598594%22"
"MONDO_0100096","COVID-19","CHEMBL131","PREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04765371%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371523%22,https://clinicaltrials.gov/search?id=%22NCT04328272%22,https://clinicaltrials.gov/search?id=%22NCT04330144%22,https://clinicaltrials.gov/search?id=%22NCT04352933%22,https://clinicaltrials.gov/search?id=%22NCT04372017%22,https://clinicaltrials.gov/search?id=%22NCT04352946%22,https://clinicaltrials.gov/search?id=%22NCT04338698%22,https://clinicaltrials.gov/search?id=%22NCT04336748%22,https://clinicaltrials.gov/search?id=%22NCT04347512%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4C","phosphodiesterase 4C",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04590586%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARA","retinoic acid receptor alpha",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04353180%22,https://clinicaltrials.gov/search?id=%22NCT04361422%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB1","gamma-aminobutyric acid type A receptor subunit beta1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04363450%22,https://clinicaltrials.gov/search?id=%22NCT04355052%22,https://clinicaltrials.gov/search?id=%22NCT04318015%22,https://clinicaltrials.gov/search?id=%22NCT04347980%22,https://clinicaltrials.gov/search?id=%22NCT04359953%22,https://clinicaltrials.gov/search?id=%22NCT04858633%22,https://clinicaltrials.gov/search?id=%22NCT04344379%22,https://clinicaltrials.gov/search?id=%22NCT04341727%22,https://clinicaltrials.gov/search?id=%22NCT04334382%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA5","gamma-aminobutyric acid type A receptor subunit alpha5",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04364009%22"
"MONDO_0100096","COVID-19","CHEMBL1536","ERGOCALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04483635%22"
"MONDO_0100096","COVID-19","CHEMBL787","MONTELUKAST","Small molecule","Cysteinyl leukotriene receptor 1 antagonist","Antagonist","CYSLTR1","cysteinyl leukotriene receptor 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04695704%22,https://clinicaltrials.gov/search?id=%22NCT04389411%22"
"MONDO_0100096","COVID-19","CHEMBL192","SILDENAFIL","Small molecule","Phosphodiesterase 5A inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04304313%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB1","gamma-aminobutyric acid type A receptor subunit beta1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL23","DILTIAZEM","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1D","calcium voltage-gated channel subunit alpha1 D",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04372082%22"
"MONDO_0100096","COVID-19","CHEMBL877","TRANEXAMIC ACID","Small molecule","Plasminogen inhibitor","Inhibitor","PLG","plasminogen",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04550338%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL4297717","CD24FC","Unknown","Heat shock protein HSP90 inhibitor","Inhibitor","HSP90AA1","heat shock protein 90 alpha family class A member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04317040%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","Serotonin 2a (5-HT2a) receptor antagonist","Antagonist","HTR2A","5-hydroxytryptamine receptor 2A",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04366739%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG2","gamma-aminobutyric acid type A receptor subunit gamma2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA3","gamma-aminobutyric acid type A receptor subunit alpha3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04409483%22,https://clinicaltrials.gov/search?id=%22NCT04365582%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA3","gamma-aminobutyric acid type A receptor subunit alpha3",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1042","CHOLECALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04385940%22,https://clinicaltrials.gov/search?id=%22NCT04780061%22,https://clinicaltrials.gov/search?id=%22NCT04641195%22,https://clinicaltrials.gov/search?id=%22NCT04502667%22,https://clinicaltrials.gov/search?id=%22NCT04535791%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 10 opener","Opener","KCNK10","potassium two pore domain channel subfamily K member 10",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04536051%22,https://clinicaltrials.gov/search?id=%22NCT04673214%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04342156%22,https://clinicaltrials.gov/search?id=%22NCT04361461%22,https://clinicaltrials.gov/search?id=%22NCT04365582%22,https://clinicaltrials.gov/search?id=%22NCT04371406%22,https://clinicaltrials.gov/search?id=%22NCT04349228%22,https://clinicaltrials.gov/search?id=%22NCT04364815%22,https://clinicaltrials.gov/search?id=%22NCT04372082%22,https://clinicaltrials.gov/search?id=%22NCT04346329%22,https://clinicaltrials.gov/search?id=%22NCT04360759%22,https://clinicaltrials.gov/search?id=%22NCT04365231%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04492475%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04647669%22"
"MONDO_0100096","COVID-19","CHEMBL2035187","PACRITINIB","Small molecule","Tyrosine-protein kinase receptor FLT3 inhibitor","Inhibitor","FLT3","fms related receptor tyrosine kinase 3",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04404361%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04446104%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04409483%22,https://clinicaltrials.gov/search?id=%22NCT04365582%22"
"MONDO_0100096","COVID-19","CHEMBL635","PREDNISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04451174%22"
"MONDO_0100096","COVID-19","CHEMBL2040682","CICLESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04377711%22"
"MONDO_0100096","COVID-19","CHEMBL2364655","EVOLOCUMAB","Antibody","Subtilisin/kexin type 9 inhibitor","Inhibitor","PCSK9","proprotein convertase subtilisin/kexin type 9",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04941105%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04392427%22"
"MONDO_0100096","COVID-19","CHEMBL1487","ATORVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04952350%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2D","glutamate ionotropic receptor NMDA type subunit 2D",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN3B","glutamate ionotropic receptor NMDA type subunit 3B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04952519%22,https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL4297717","CD24FC","Unknown","Heat shock protein HSP90 inhibitor","Inhibitor","HSP90AB1","heat shock protein 90 alpha family class B member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04317040%22"
"MONDO_0100096","COVID-19","CHEMBL1161","MOMETASONE FUROATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04484493%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04345848%22,https://clinicaltrials.gov/search?id=%22NCT04483960%22,https://clinicaltrials.gov/search?id=%22NCT04492254%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04446104%22"
"MONDO_0100096","COVID-19","CHEMBL1042","CHOLECALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04344041%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04361461%22,https://clinicaltrials.gov/search?id=%22NCT04360759%22,https://clinicaltrials.gov/search?id=%22NCT04372082%22,https://clinicaltrials.gov/search?id=%22NCT04365582%22,https://clinicaltrials.gov/search?id=%22NCT04346329%22,https://clinicaltrials.gov/search?id=%22NCT04365231%22,https://clinicaltrials.gov/search?id=%22NCT04349228%22,https://clinicaltrials.gov/search?id=%22NCT04342156%22,https://clinicaltrials.gov/search?id=%22NCT04364815%22,https://clinicaltrials.gov/search?id=%22NCT04371406%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04303299%22,https://clinicaltrials.gov/search?id=%22NCT04261270%22,https://clinicaltrials.gov/search?id=%22NCT04321174%22"
"MONDO_0100096","COVID-19","CHEMBL3900409","AZD-7986","Small molecule","Dipeptidyl peptidase I inhibitor","Inhibitor","CTSC","cathepsin C",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04817332%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA2A","adrenoceptor alpha 2A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04843761%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04361032%22,https://clinicaltrials.gov/search?id=%22NCT04345445%22"
"MONDO_0100096","COVID-19","CHEMBL1560","CAPTOPRIL","Small molecule","Angiotensin-converting enzyme inhibitor","Inhibitor","ACE","angiotensin I converting enzyme",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04345406%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRE","gamma-aminobutyric acid type A receptor subunit epsilon",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN1","glutamate ionotropic receptor NMDA type subunit 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA5","gamma-aminobutyric acid type A receptor subunit alpha5",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22,https://clinicaltrials.gov/search?id=%22NCT04328480%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04640168%22"
"MONDO_0100096","COVID-19","CHEMBL1201823","ABATACEPT","Protein","T-lymphocyte activation antigen CD80 inhibitor","Inhibitor","CD80","CD80 molecule",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04593940%22"
"MONDO_0100096","COVID-19","CHEMBL434394","NEBIVOLOL","Small molecule","Beta-2 adrenergic receptor antagonist","Antagonist","ADRB2","adrenoceptor beta 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04631536%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6G","phosphodiesterase 6G",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL23","DILTIAZEM","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1C","calcium voltage-gated channel subunit alpha1 C",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04372082%22"
"MONDO_0100096","COVID-19","CHEMBL154","NAPROXEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04325633%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04362137%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04342221%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","D2-like dopamine receptor antagonist","Antagonist","DRD2","dopamine receptor D2",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04366739%22"
"MONDO_0100096","COVID-19","CHEMBL1473","FLUTICASONE PROPIONATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04885530%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04362111%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04315948%22,https://clinicaltrials.gov/search?id=%22NCT04328285%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2D","glutamate ionotropic receptor NMDA type subunit 2D",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894617%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04678739%22,https://clinicaltrials.gov/search?id=%22NCT04409262%22,https://clinicaltrials.gov/search?id=%22NCT04356937%22,https://clinicaltrials.gov/search?id=%22NCT04320615%22,https://clinicaltrials.gov/search?id=%22NCT04577534%22"
"MONDO_0100096","COVID-19","CHEMBL814","FLUVOXAMINE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04668950%22"
"MONDO_0100096","COVID-19","CHEMBL2110727","CENICRIVIROC","Small molecule","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04593940%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG1","gamma-aminobutyric acid type A receptor subunit gamma1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Vanilloid receptor opener","Opener","TRPV1","transient receptor potential cation channel subfamily V member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04673214%22,https://clinicaltrials.gov/search?id=%22NCT04536051%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG1","gamma-aminobutyric acid type A receptor subunit gamma1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL191","LOSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04606563%22"
"MONDO_0100096","COVID-19","CHEMBL1743070","SILTUXIMAB","Antibody","Interleukin-6 inhibitor","Antagonist","IL6","interleukin 6",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04330638%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04364022%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04472611%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04377620%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04343001%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","Potassium channel subfamily K member 10 opener","Opener","KCNK10","potassium two pore domain channel subfamily K member 10",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1201081","METHYLPREDNISOLONE SODIUM SUCCINATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04826588%22"
"MONDO_0100096","COVID-19","CHEMBL635","PREDNISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04359511%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04372017%22,https://clinicaltrials.gov/search?id=%22NCT04338698%22,https://clinicaltrials.gov/search?id=%22NCT04352946%22,https://clinicaltrials.gov/search?id=%22NCT04352933%22,https://clinicaltrials.gov/search?id=%22NCT04328272%22,https://clinicaltrials.gov/search?id=%22NCT04371523%22,https://clinicaltrials.gov/search?id=%22NCT04347512%22,https://clinicaltrials.gov/search?id=%22NCT04336748%22,https://clinicaltrials.gov/search?id=%22NCT04330144%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL2110727","CENICRIVIROC","Small molecule","C-C chemokine receptor type 2 antagonist","Antagonist","CCR2","C-C motif chemokine receptor 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04593940%22"
"MONDO_0100096","COVID-19","CHEMBL1422","SITAGLIPTIN","Small molecule","Dipeptidyl peptidase IV inhibitor","Inhibitor","DPP4","dipeptidyl peptidase 4",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04365517%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04364022%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04328285%22,https://clinicaltrials.gov/search?id=%22NCT04334928%22,https://clinicaltrials.gov/search?id=%22NCT04315896%22,https://clinicaltrials.gov/search?id=%22NCT04322123%22,https://clinicaltrials.gov/search?id=%22NCT04411433%22,https://clinicaltrials.gov/search?id=%22NCT04315948%22,https://clinicaltrials.gov/search?id=%22NCT04344444%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04472611%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB2","gamma-aminobutyric acid type A receptor subunit beta2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL231779","APIXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04498273%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22,https://clinicaltrials.gov/search?id=%22NCT04667780%22"
"MONDO_0100096","COVID-19","CHEMBL2095208","COBICISTAT","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04252274%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 2 opener","Opener","KCNK2","potassium two pore domain channel subfamily K member 2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA1","gamma-aminobutyric acid type A receptor subunit alpha1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA3","gamma-aminobutyric acid type A receptor subunit alpha3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1487","ATORVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04486508%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4B","phosphodiesterase 4B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04341727%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 9 opener","Opener","KCNK9","potassium two pore domain channel subfamily K member 9",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04504240%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04516941%22,https://clinicaltrials.gov/search?id=%22NCT04416334%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04724629%22,https://clinicaltrials.gov/search?id=%22NCT04472611%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04372186%22,https://clinicaltrials.gov/search?id=%22NCT04330638%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04486508%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04421027%22,https://clinicaltrials.gov/search?id=%22NCT04401579%22"
"MONDO_0100096","COVID-19","CHEMBL393220","ATORVASTATIN CALCIUM","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04801940%22,https://clinicaltrials.gov/search?id=%22NCT04631536%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04377620%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1C","phosphodiesterase 1C",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4A","phosphodiesterase 4A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04344444%22,https://clinicaltrials.gov/search?id=%22NCT04322123%22,https://clinicaltrials.gov/search?id=%22NCT04328285%22,https://clinicaltrials.gov/search?id=%22NCT04411433%22,https://clinicaltrials.gov/search?id=%22NCT04334928%22,https://clinicaltrials.gov/search?id=%22NCT04315948%22,https://clinicaltrials.gov/search?id=%22NCT04315896%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04498273%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Vascular endothelial growth factor receptor inhibitor","Inhibitor","FLT1","fms related receptor tyrosine kinase 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04970719%22,https://clinicaltrials.gov/search?id=%22NCT04890626%22,https://clinicaltrials.gov/search?id=%22NCT04693026%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Platelet-derived growth factor receptor inhibitor","Inhibitor","PDGFRB","platelet derived growth factor receptor beta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL514800","APREMILAST","Small molecule","Phosphodiesterase 4 inhibitor","Inhibitor","PDE4B","phosphodiesterase 4B",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04590586%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IFNLR1","interferon lambda receptor 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04342156%22,https://clinicaltrials.gov/search?id=%22NCT04361461%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL1569","AMANTADINE HYDROCHLORIDE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2B","glutamate ionotropic receptor NMDA type subunit 2B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL1743034","IXEKIZUMAB","Antibody","Interleukin 17A inhibitor","Inhibitor","IL17A","interleukin 17A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04724629%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL2108730","SARILUMAB","Antibody","Interleukin-6 receptor alpha subunit antagonist","Antagonist","IL6R","interleukin 6 receptor",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04327388%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE10A","phosphodiesterase 10A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","Potassium channel subfamily K member 3 opener","Opener","KCNK3","potassium two pore domain channel subfamily K member 3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA5","gamma-aminobutyric acid type A receptor subunit alpha5",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL154","NAPROXEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04325633%22"
"MONDO_0100096","COVID-19","CHEMBL1487","ATORVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04631536%22,https://clinicaltrials.gov/search?id=%22NCT04801940%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",3,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04339816%22,https://clinicaltrials.gov/search?id=%22NCT04341441%22,https://clinicaltrials.gov/search?id=%22NCT04342221%22,https://clinicaltrials.gov/search?id=%22NCT04522466%22,https://clinicaltrials.gov/search?id=%22NCT04329611%22,https://clinicaltrials.gov/search?id=%22NCT04345692%22,https://clinicaltrials.gov/search?id=%22NCT04421664%22,https://clinicaltrials.gov/search?id=%22NCT04374942%22,https://clinicaltrials.gov/search?id=%22NCT04325893%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22,https://clinicaltrials.gov/search?id=%22NCT04324463%22,https://clinicaltrials.gov/search?id=%22NCT04483960%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04343001%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRA4","gamma-aminobutyric acid type A receptor subunit alpha4",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARG","retinoic acid receptor gamma",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04353180%22,https://clinicaltrials.gov/search?id=%22NCT04361422%22"
"MONDO_0100096","COVID-19","CHEMBL1201823","ABATACEPT","Protein","T-lymphocyte activation antigen CD86 inhibitor","Inhibitor","CD86","CD86 molecule",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04593940%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04600141%22,https://clinicaltrials.gov/search?id=%22NCT04412772%22,https://clinicaltrials.gov/search?id=%22NCT04361552%22,https://clinicaltrials.gov/search?id=%22NCT04693026%22"
"MONDO_0100096","COVID-19","CHEMBL393220","ATORVASTATIN CALCIUM","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04952350%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE9A","phosphodiesterase 9A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRD","gamma-aminobutyric acid type A receptor subunit delta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6H","phosphodiesterase 6H",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04486508%22"
"MONDO_0100096","COVID-19","CHEMBL2035187","PACRITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04404361%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8B","phosphodiesterase 8B",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 10 opener","Opener","KCNK10","potassium two pore domain channel subfamily K member 10",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04554433%22"
"MONDO_0100096","COVID-19","CHEMBL1088752","LOSMAPIMOD","Small molecule","MAP kinase p38 beta inhibitor","Inhibitor","MAPK11","mitogen-activated protein kinase 11",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04511819%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG3","gamma-aminobutyric acid type A receptor subunit gamma3",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3A","phosphodiesterase 3A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04341727%22,https://clinicaltrials.gov/search?id=%22NCT04858633%22,https://clinicaltrials.gov/search?id=%22NCT04347980%22,https://clinicaltrials.gov/search?id=%22NCT04334382%22,https://clinicaltrials.gov/search?id=%22NCT04363450%22,https://clinicaltrials.gov/search?id=%22NCT04359953%22,https://clinicaltrials.gov/search?id=%22NCT04355052%22,https://clinicaltrials.gov/search?id=%22NCT04344379%22,https://clinicaltrials.gov/search?id=%22NCT04318015%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4C","phosphodiesterase 4C",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","Potassium channel subfamily K member 3 opener","Opener","KCNK3","potassium two pore domain channel subfamily K member 3",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG1","gamma-aminobutyric acid type A receptor subunit gamma1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL389621","HYDROCORTISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04359511%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRB2","gamma-aminobutyric acid type A receptor subunit beta2",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL191","LOSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04343001%22"
"MONDO_0100096","COVID-19","CHEMBL269732","TACROLIMUS","Small molecule","FK506-binding protein 1A inhibitor","Inhibitor","FKBP1A","FKBP prolyl isomerase 1A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04341038%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04523831%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04832880%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRQ","gamma-aminobutyric acid type A receptor subunit theta",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",3,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04330638%22,https://clinicaltrials.gov/search?id=%22NCT04680949%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04539873%22"
"MONDO_0100096","COVID-19","CHEMBL1409","FLUVOXAMINE MALEATE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL2095208","COBICISTAT","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04252274%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",3,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04371952%22"
"MONDO_0100096","COVID-19","CHEMBL1200694","SEVOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRP","gamma-aminobutyric acid type A receptor subunit pi",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355962%22"
"MONDO_0100096","COVID-19","CHEMBL409","BICALUTAMIDE","Small molecule","Androgen Receptor antagonist","Antagonist","AR","androgen receptor",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04509999%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04667780%22,https://clinicaltrials.gov/search?id=%22NCT04328480%22,https://clinicaltrials.gov/search?id=%22NCT04350320%22,https://clinicaltrials.gov/search?id=%22NCT04322682%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04603690%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04492475%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04303299%22,https://clinicaltrials.gov/search?id=%22NCT04261270%22,https://clinicaltrials.gov/search?id=%22NCT04321174%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRP","gamma-aminobutyric acid type A receptor subunit pi",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IL10RB","interleukin 10 receptor subunit beta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04727424%22"
"MONDO_0100096","COVID-19","CHEMBL650","METHYLPREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04485429%22,https://clinicaltrials.gov/search?id=%22NCT04499313%22,https://clinicaltrials.gov/search?id=%22NCT04909918%22,https://clinicaltrials.gov/search?id=%22NCT04341038%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04732949%22"
"MONDO_0100096","COVID-19","CHEMBL1201834","CANAKINUMAB","Antibody","Interleukin-1 beta inhibitor","Inhibitor","IL1B","interleukin 1 beta",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04362813%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04420247%22,https://clinicaltrials.gov/search?id=%22NCT04331834%22,https://clinicaltrials.gov/search?id=%22NCT04328467%22,https://clinicaltrials.gov/search?id=%22NCT04446104%22,https://clinicaltrials.gov/search?id=%22NCT04334148%22,https://clinicaltrials.gov/search?id=%22NCT04308668%22,https://clinicaltrials.gov/search?id=%22NCT04391127%22,https://clinicaltrials.gov/search?id=%22NCT04358081%22,https://clinicaltrials.gov/search?id=%22NCT04321278%22,https://clinicaltrials.gov/search?id=%22NCT04261517%22,https://clinicaltrials.gov/search?id=%22NCT04332991%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04603729%22"
"MONDO_0100096","COVID-19","CHEMBL1201438","ALDESLEUKIN","Protein","Interleukin-2 receptor agonist","Agonist","IL2RB","interleukin 2 receptor subunit beta",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04724629%22"
"MONDO_0100096","COVID-19","CHEMBL650","METHYLPREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",3,"Completed","https://clinicaltrials.gov/search?id=%22NCT04438980%22,https://clinicaltrials.gov/search?id=%22NCT04603729%22"
"MONDO_0100096","COVID-19","CHEMBL1256","ISOFLURANE","Small molecule","GABA-A receptor; anion channel positive allosteric modulator","Positive allosteric modulator","GABRG3","gamma-aminobutyric acid type A receptor subunit gamma3",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415060%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1A","phosphodiesterase 1A",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04410328%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",3,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04528927%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Platelet-derived growth factor receptor inhibitor","Inhibitor","PDGFRA","platelet derived growth factor receptor alpha",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04541680%22"
"MONDO_0100096","COVID-19","CHEMBL660","AMANTADINE","Small molecule","Glutamate [NMDA] receptor antagonist","Antagonist","GRIN2C","glutamate ionotropic receptor NMDA type subunit 2C",3,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04952519%22,https://clinicaltrials.gov/search?id=%22NCT04854759%22"
"MONDO_0100096","COVID-19","CHEMBL4297879",".ALPHA.1-PROTEINASE INHIBITOR HUMAN","Protein","Leukocyte elastase inhibitor","Inhibitor","ELANE","elastase, neutrophil expressed",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04547140%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND4","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL135","ESTRADIOL","Small molecule","Estrogen receptor alpha agonist","Agonist","ESR1","estrogen receptor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04359329%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B1","guanylate cyclase 1 soluble subunit beta 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04338828%22,https://clinicaltrials.gov/search?id=%22NCT04388683%22,https://clinicaltrials.gov/search?id=%22NCT04312243%22,https://clinicaltrials.gov/search?id=%22NCT04306393%22,https://clinicaltrials.gov/search?id=%22NCT04305457%22"
"MONDO_0100096","COVID-19","CHEMBL2393130","APABETALONE","Small molecule","Bromodomain and extra-terminal motif (BET) inhibitor","Inhibitor","BRDT","bromodomain testis associated",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894266%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB2","NADH:ubiquinone oxidoreductase subunit B2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS4","NADH:ubiquinone oxidoreductase subunit S4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04357366%22,https://clinicaltrials.gov/search?id=%22NCT04412291%22"
"MONDO_0100096","COVID-19","CHEMBL6966","VERAPAMIL","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1D","calcium voltage-gated channel subunit alpha1 D",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351763%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CG","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN7A","sodium voltage-gated channel alpha subunit 7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04385095%22"
"MONDO_0100096","COVID-19","CHEMBL38","TRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARG","retinoic acid receptor gamma",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04396067%22,https://clinicaltrials.gov/search?id=%22NCT04568096%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF4","NADH:ubiquinone oxidoreductase complex assembly factor 4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL395429","OXYTOCIN","Protein","Oxytocin receptor agonist","Agonist","OXTR","oxytocin receptor",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04386447%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB7","NADH:ubiquinone oxidoreductase subunit B7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04389359%22,https://clinicaltrials.gov/search?id=%22NCT04374552%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL409","BICALUTAMIDE","Small molecule","Androgen Receptor antagonist","Antagonist","AR","androgen receptor",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04374279%22"
"MONDO_0100096","COVID-19","CHEMBL3219124","AZD-1656","Small molecule","Hexokinase type IV activator","Activator","GCK","glucokinase",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04516759%22"
"MONDO_0100096","COVID-19","CHEMBL941","IMATINIB","Small molecule","Stem cell growth factor receptor inhibitor","Inhibitor","KIT","KIT proto-oncogene, receptor tyrosine kinase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04346147%22"
"MONDO_0100096","COVID-19","CHEMBL1201583","BEVACIZUMAB","Antibody","Vascular endothelial growth factor A inhibitor","Inhibitor","VEGFA","vascular endothelial growth factor A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04275414%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04521400%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04492358%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04329832%22,https://clinicaltrials.gov/search?id=%22NCT04363827%22,https://clinicaltrials.gov/search?id=%22NCT04336332%22,https://clinicaltrials.gov/search?id=%22NCT04860284%22,https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL814","FLUVOXAMINE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",2,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04711863%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7B","phosphodiesterase 7B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04317092%22,https://clinicaltrials.gov/search?id=%22NCT04363853%22,https://clinicaltrials.gov/search?id=%22NCT04315480%22,https://clinicaltrials.gov/search?id=%22NCT04377659%22,https://clinicaltrials.gov/search?id=%22NCT04331808%22"
"MONDO_0100096","COVID-19","CHEMBL1762621","BARDOXOLONE METHYL","Small molecule","Keap1/Nrf2 inhibitor","Inhibitor","KEAP1","kelch like ECH associated protein 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04494646%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA2","NADH:ubiquinone oxidoreductase subunit A2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL1201129","DECITABINE","Small molecule","DNA (cytosine-5)-methyltransferase 3A inhibitor","Inhibitor","DNMT3A","DNA methyltransferase 3 alpha",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04482621%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA1D","adrenoceptor alpha 1D",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04360096%22,https://clinicaltrials.gov/search?id=%22NCT04844580%22,https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL4297865","ABIVERTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04440007%22"
"MONDO_0100096","COVID-19","CHEMBL6966","VERAPAMIL","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1F","calcium voltage-gated channel subunit alpha1 F",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351763%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS3","NADH:ubiquinone oxidoreductase core subunit S3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CB","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL4594463","AVDORALIMAB","Antibody","C5a anaphylatoxin chemotactic receptor inhibitor","Inhibitor","C5AR1","complement C5a receptor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04333914%22"
"MONDO_0100096","COVID-19","CHEMBL1536","ERGOCALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04335084%22,https://clinicaltrials.gov/search?id=%22NCT04334512%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04358614%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4B","phosphodiesterase 4B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL118","CELECOXIB","Small molecule","Cyclooxygenase-2 inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R5","phosphoinositide-3-kinase regulatory subunit 5",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL314854","FINGOLIMOD","Small molecule","Sphingosine 1-phosphate receptor agonist","Agonist","S1PR1","sphingosine-1-phosphate receptor 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04280588%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04359290%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA7","NADH:ubiquinone oxidoreductase subunit A7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL2108589","CLAZAKIZUMAB","Antibody","Interleukin-6 inhibitor","Inhibitor","IL6","interleukin 6",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343989%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8B","phosphodiesterase 8B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04385264%22"
"MONDO_0100096","COVID-19","CHEMBL314854","FINGOLIMOD","Small molecule","Sphingosine 1-phosphate receptor agonist","Agonist","S1PR2","sphingosine-1-phosphate receptor 2",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04280588%22"
"MONDO_0100096","COVID-19","CHEMBL916","TIROFIBAN","Small molecule","Integrin alpha-IIb/beta-3 inhibitor","Inhibitor","ITGA2B","integrin subunit alpha 2b",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04368377%22"
"MONDO_0100096","COVID-19","CHEMBL1201476","ENOXAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04640181%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL1201593","ALTEPLASE","Enzyme","Plasminogen activator","Activator","PLG","plasminogen",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04356833%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R1","phosphoinositide-3-kinase regulatory subunit 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK3","Janus kinase 3",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04750317%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA6","NADH:ubiquinone oxidoreductase subunit A6",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL2028852","ICATIBANT ACETATE","Protein","Bradykinin B2 receptor antagonist","Antagonist","BDKRB2","bradykinin receptor B2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04978051%22"
"MONDO_0100096","COVID-19","CHEMBL1655","TOREMIFENE","Small molecule","Estrogen receptor modulator","Modulator","ESR1","estrogen receptor 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04531748%22"
"MONDO_0100096","COVID-19","CHEMBL4297886","ASUNERCEPT","Protein","Tumor necrosis factor ligand superfamily member 6 binding agent","Binding agent","FASLG","Fas ligand",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351724%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04477993%22,https://clinicaltrials.gov/search?id=%22NCT04366232%22"
"MONDO_0100096","COVID-19","CHEMBL1762621","BARDOXOLONE METHYL","Small molecule","Peroxisome proliferator-activated receptor gamma antagonist","Antagonist","PPARG","peroxisome proliferator activated receptor gamma",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04494646%22"
"MONDO_0100096","COVID-19","CHEMBL3990029","RISANKIZUMAB","Antibody","Interleukin-23 inhibitor","Inhibitor","IL23A","interleukin 23 subunit alpha",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04583956%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFC1","NADH:ubiquinone oxidoreductase subunit C1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1873475","IBRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04375397%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04412252%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1B","melatonin receptor 1B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04474483%22,https://clinicaltrials.gov/search?id=%22NCT04784754%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN1A","sodium voltage-gated channel alpha subunit 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415151%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS3","NADH:ubiquinone oxidoreductase core subunit S3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA13","NADH:ubiquinone oxidoreductase subunit A13",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04459702%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA10","NADH:ubiquinone oxidoreductase subunit A10",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04276688%22,https://clinicaltrials.gov/search?id=%22NCT04343768%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04750317%22"
"MONDO_0100096","COVID-19","CHEMBL3707348","ACALABRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04380688%22,https://clinicaltrials.gov/search?id=%22NCT04346199%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA9","NADH:ubiquinone oxidoreductase subunit A9",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL2108730","SARILUMAB","Antibody","Interleukin-6 receptor alpha subunit antagonist","Antagonist","IL6R","interleukin 6 receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04341870%22,https://clinicaltrials.gov/search?id=%22NCT04661527%22"
"MONDO_0100096","COVID-19","CHEMBL877","TRANEXAMIC ACID","Small molecule","Plasminogen inhibitor","Inhibitor","PLG","plasminogen",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04338074%22"
"MONDO_0100096","COVID-19","CHEMBL2040682","CICLESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04435795%22"
"MONDO_0100096","COVID-19","CHEMBL1200500","BECLOMETHASONE DIPROPIONATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04937543%22"
"MONDO_0100096","COVID-19","CHEMBL2108589","CLAZAKIZUMAB","Antibody","Interleukin-6 inhibitor","Inhibitor","IL6","interleukin 6",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04363502%22,https://clinicaltrials.gov/search?id=%22NCT04494724%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND6","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04363736%22,https://clinicaltrials.gov/search?id=%22NCT04445272%22,https://clinicaltrials.gov/search?id=%22NCT04339712%22,https://clinicaltrials.gov/search?id=%22NCT04331795%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND1","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B2","guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04337918%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","FGR","FGR proto-oncogene, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04712279%22,https://clinicaltrials.gov/search?id=%22NCT04350450%22,https://clinicaltrials.gov/search?id=%22NCT04400019%22,https://clinicaltrials.gov/search?id=%22NCT04361318%22,https://clinicaltrials.gov/search?id=%22NCT04354441%22,https://clinicaltrials.gov/search?id=%22NCT04437693%22,https://clinicaltrials.gov/search?id=%22NCT04359537%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04320277%22"
"MONDO_0100096","COVID-19","CHEMBL393220","ATORVASTATIN CALCIUM","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04380402%22,https://clinicaltrials.gov/search?id=%22NCT04466241%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04276688%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3B","phosphodiesterase 3B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1201581","INFLIXIMAB","Antibody","TNF-alpha inhibitor","Inhibitor","TNF","tumor necrosis factor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04922827%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRD1","opioid receptor delta 1",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL2109343","LERONLIMAB","Antibody","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04343651%22,https://clinicaltrials.gov/search?id=%22NCT04678830%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK3","Janus kinase 3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04332042%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK3","Janus kinase 3",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04412252%22"
"MONDO_0100096","COVID-19","CHEMBL1655","TOREMIFENE","Small molecule","Estrogen receptor modulator","Modulator","ESR2","estrogen receptor 2",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04531748%22"
"MONDO_0100096","COVID-19","CHEMBL2","PRAZOSIN","Small molecule","Adrenergic receptor alpha-1 antagonist","Antagonist","ADRA1A","adrenoceptor alpha 1A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365257%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB10","NADH:ubiquinone oxidoreductase subunit B10",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354441%22,https://clinicaltrials.gov/search?id=%22NCT04359537%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA4","NDUFA4 mitochondrial complex associated",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL4594463","AVDORALIMAB","Antibody","C5a anaphylatoxin chemotactic receptor inhibitor","Inhibitor","C5AR1","complement C5a receptor 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04371367%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6H","phosphodiesterase 6H",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1139","EPOPROSTENOL","Small molecule","Prostanoid IP receptor agonist","Agonist","PTGIR","prostaglandin I2 receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04452669%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4A","phosphodiesterase 4A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04321993%22,https://clinicaltrials.gov/search?id=%22NCT04891133%22,https://clinicaltrials.gov/search?id=%22NCT04346147%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA8","NADH:ubiquinone oxidoreductase subunit A8",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04459286%22,https://clinicaltrials.gov/search?id=%22NCT04331470%22,https://clinicaltrials.gov/search?id=%22NCT04351724%22,https://clinicaltrials.gov/search?id=%22NCT04499677%22,https://clinicaltrials.gov/search?id=%22NCT04372628%22,https://clinicaltrials.gov/search?id=%22NCT04466241%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS8","NADH:ubiquinone oxidoreductase core subunit S8",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA5","NADH:ubiquinone oxidoreductase subunit A5",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFV1","NADH:ubiquinone oxidoreductase core subunit V1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04407130%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354441%22,https://clinicaltrials.gov/search?id=%22NCT04359537%22"
"MONDO_0100096","COVID-19","CHEMBL2","PRAZOSIN","Small molecule","Adrenergic receptor alpha-1 antagonist","Antagonist","ADRA1B","adrenoceptor alpha 1B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365257%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1256786","FORMOTEROL","Small molecule","Beta-2 adrenergic receptor agonist","Agonist","ADRB2","adrenoceptor beta 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04331470%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS5","NADH:ubiquinone oxidoreductase subunit S5",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1471","APREPITANT","Small molecule","Neurokinin 1 receptor antagonist","Antagonist","TACR1","tachykinin receptor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04470622%22"
"MONDO_0100096","COVID-19","CHEMBL1201414","TINZAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04344756%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND2","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL198362","RIVAROXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351724%22,https://clinicaltrials.gov/search?id=%22NCT04416048%22"
"MONDO_0100096","COVID-19","CHEMBL3545185","SELINEXOR","Small molecule","Exportin-1 inhibitor","Inhibitor","XPO1","exportin 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04355676%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04336332%22,https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL4297787","MONALIZUMAB","Antibody","NKG2-A/NKG2-B type II integral membrane protein inhibitor","Inhibitor","KLRC1","killer cell lectin like receptor C1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04333914%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1B","melatonin receptor 1B",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04353128%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFV3","NADH:ubiquinone oxidoreductase subunit V3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3A","phosphodiesterase 3A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04348071%22"
"MONDO_0100096","COVID-19","CHEMBL1536","ERGOCALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04363840%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Anandamide amidohydrolase inhibitor","Inhibitor","FAAH","fatty acid amide hydrolase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04920838%22,https://clinicaltrials.gov/search?id=%22NCT04532931%22"
"MONDO_0100096","COVID-19","CHEMBL1201129","DECITABINE","Small molecule","DNA (cytosine-5)-methyltransferase 1 inhibitor","Inhibitor","DNMT1","DNA methyltransferase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04482621%22"
"MONDO_0100096","COVID-19","CHEMBL2393130","APABETALONE","Small molecule","Bromodomain and extra-terminal motif (BET) inhibitor","Inhibitor","BRD3","bromodomain containing 3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894266%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA5","NADH:ubiquinone oxidoreductase subunit A5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS4","NADH:ubiquinone oxidoreductase subunit S4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1B","phosphodiesterase 1B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1256786","FORMOTEROL","Small molecule","Beta-2 adrenergic receptor agonist","Agonist","ADRB2","adrenoceptor beta 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04937543%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB9","NADH:ubiquinone oxidoreductase subunit B9",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA3","NADH:ubiquinone oxidoreductase subunit A3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA3","NADH:ubiquinone oxidoreductase subunit A3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04373044%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1201335","GLYCOPYRRONIUM","Small molecule","Muscarinic acetylcholine receptor M1 antagonist","Antagonist","CHRM1","cholinergic receptor muscarinic 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04937543%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04482686%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04621149%22,https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL916","TIROFIBAN","Small molecule","Integrin alpha-IIb/beta-3 inhibitor","Inhibitor","ITGB3","integrin subunit beta 3",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04368377%22"
"MONDO_0100096","COVID-19","CHEMBL1042","CHOLECALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04395768%22,https://clinicaltrials.gov/search?id=%22NCT04482686%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB2","NADH:ubiquinone oxidoreductase subunit B2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB5","NADH:ubiquinone oxidoreductase subunit B5",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL4297879",".ALPHA.1-PROTEINASE INHIBITOR HUMAN","Protein","Leukocyte elastase inhibitor","Inhibitor","ELANE","elastase, neutrophil expressed",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04495101%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22"
"MONDO_0100096","COVID-19","CHEMBL1873475","IBRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04439006%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04328961%22,https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04350281%22,https://clinicaltrials.gov/search?id=%22NCT04333225%22,https://clinicaltrials.gov/search?id=%22NCT04343768%22,https://clinicaltrials.gov/search?id=%22NCT04354870%22,https://clinicaltrials.gov/search?id=%22NCT04345653%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN9A","sodium voltage-gated channel alpha subunit 9",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04347889%22,https://clinicaltrials.gov/search?id=%22NCT04575558%22,https://clinicaltrials.gov/search?id=%22NCT04363866%22,https://clinicaltrials.gov/search?id=%22NCT04459702%22,https://clinicaltrials.gov/search?id=%22NCT04351516%22,https://clinicaltrials.gov/search?id=%22NCT04374552%22,https://clinicaltrials.gov/search?id=%22NCT04379492%22,https://clinicaltrials.gov/search?id=%22NCT04389359%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04373044%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA1","NADH:ubiquinone oxidoreductase subunit A1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFC1","NADH:ubiquinone oxidoreductase subunit C1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04521400%22,https://clinicaltrials.gov/search?id=%22NCT04960202%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04363866%22,https://clinicaltrials.gov/search?id=%22NCT04389359%22,https://clinicaltrials.gov/search?id=%22NCT04459702%22,https://clinicaltrials.gov/search?id=%22NCT04575558%22,https://clinicaltrials.gov/search?id=%22NCT04374552%22,https://clinicaltrials.gov/search?id=%22NCT04379492%22,https://clinicaltrials.gov/search?id=%22NCT04347889%22,https://clinicaltrials.gov/search?id=%22NCT04351516%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB11","NADH:ubiquinone oxidoreductase subunit B11",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1201563","INTERFERON BETA-1B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343768%22,https://clinicaltrials.gov/search?id=%22NCT04276688%22,https://clinicaltrials.gov/search?id=%22NCT04350281%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R3","phosphoinositide-3-kinase regulatory subunit 3",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Vascular endothelial growth factor receptor inhibitor","Inhibitor","FLT1","fms related receptor tyrosine kinase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL941","IMATINIB","Small molecule","Bcr/Abl fusion protein","Inhibitor","BCR","BCR activator of RhoGEF and GTPase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04346147%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","TYK2","tyrosine kinase 2",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04412252%22"
"MONDO_0100096","COVID-19","CHEMBL1201823","ABATACEPT","Protein","T-lymphocyte activation antigen CD86 inhibitor","Inhibitor","CD86","CD86 molecule",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04472494%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R2","phosphoinositide-3-kinase regulatory subunit 2",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1A","melatonin receptor 1A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04784754%22,https://clinicaltrials.gov/search?id=%22NCT04474483%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CA","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR4","fibroblast growth factor receptor 4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R3","phosphoinositide-3-kinase regulatory subunit 3",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL812","PYRIDOSTIGMINE BROMIDE","Small molecule","Acetylcholinesterase inhibitor","Inhibitor","ACHE","acetylcholinesterase (Cartwright blood group)",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04343963%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB6","NADH:ubiquinone oxidoreductase subunit B6",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04501965%22"
"MONDO_0100096","COVID-19","CHEMBL1560","CAPTOPRIL","Small molecule","Angiotensin-converting enzyme inhibitor","Inhibitor","ACE","angiotensin I converting enzyme",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04578236%22,https://clinicaltrials.gov/search?id=%22NCT04355429%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R1","phosphoinositide-3-kinase regulatory subunit 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB8","NADH:ubiquinone oxidoreductase subunit B8",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAB1","NADH:ubiquinone oxidoreductase subunit AB1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL814","FLUVOXAMINE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22,https://clinicaltrials.gov/search?id=%22NCT04718480%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF1","NADH:ubiquinone oxidoreductase complex assembly factor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22,https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22"
"MONDO_0100096","COVID-19","CHEMBL3809489","BEMCENTINIB","Small molecule","Tyrosine-protein kinase receptor UFO inhibitor","Inhibitor","AXL","AXL receptor tyrosine kinase",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04890509%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB9","NADH:ubiquinone oxidoreductase subunit B9",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRK1","opioid receptor kappa 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04604704%22,https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04407130%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFV1","NADH:ubiquinone oxidoreductase core subunit V1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04466670%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351724%22,https://clinicaltrials.gov/search?id=%22NCT04459286%22,https://clinicaltrials.gov/search?id=%22NCT04499677%22,https://clinicaltrials.gov/search?id=%22NCT04466241%22,https://clinicaltrials.gov/search?id=%22NCT04331470%22,https://clinicaltrials.gov/search?id=%22NCT04372628%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","SRC","SRC proto-oncogene, non-receptor tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1B","melatonin receptor 1B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04568863%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS2","NADH:ubiquinone oxidoreductase core subunit S2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04605588%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04336332%22,https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL405821","SENICAPOC","Small molecule","Intermediate conductance calcium-activated potassium channel protein 4 blocker","Blocker","KCNN4","potassium calcium-activated channel subfamily N member 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04594668%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","TYK2","tyrosine kinase 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04469114%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343768%22"
"MONDO_0100096","COVID-19","CHEMBL1201563","INTERFERON BETA-1B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04350281%22,https://clinicaltrials.gov/search?id=%22NCT04276688%22,https://clinicaltrials.gov/search?id=%22NCT04343768%22"
"MONDO_0100096","COVID-19","CHEMBL135","ESTRADIOL","Small molecule","Estrogen receptor alpha agonist","Agonist","ESR1","estrogen receptor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04853069%22"
"MONDO_0100096","COVID-19","CHEMBL44657","ETOPOSIDE","Small molecule","DNA topoisomerase II inhibitor","Inhibitor","TOP2A","DNA topoisomerase II alpha",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04356690%22"
"MONDO_0100096","COVID-19","CHEMBL160","CYCLOSPORINE","Protein","Cyclophilin A modulator","Modulator","PPIA","peptidylprolyl isomerase A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL191","LOSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04643691%22,https://clinicaltrials.gov/search?id=%22NCT04328012%22"
"MONDO_0100096","COVID-19","CHEMBL1201589","OMALIZUMAB","Antibody","Ig epsilon chain C region inhibitor","Inhibitor","IGHE","immunoglobulin heavy constant epsilon",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04720612%22"
"MONDO_0100096","COVID-19","CHEMBL1908391","MASITINIB","Small molecule","Fibroblast growth factor receptor 3 inhibitor","Inhibitor","FGFR3","fibroblast growth factor receptor 3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04622865%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN3A","glutamate ionotropic receptor NMDA type subunit 3A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL635","PREDNISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04492358%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","FYN","FYN proto-oncogene, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04828564%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04374149%22"
"MONDO_0100096","COVID-19","CHEMBL2040682","CICLESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04356495%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6A","phosphodiesterase 6A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04518410%22,https://clinicaltrials.gov/search?id=%22NCT04330690%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor","Inhibitor","GPD2","glycerol-3-phosphate dehydrogenase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN2C","glutamate ionotropic receptor NMDA type subunit 2C",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial glycerol-3-phosphate dehydrogenase inhibitor","Inhibitor","GPD2","glycerol-3-phosphate dehydrogenase 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1016","CANDESARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351724%22"
"MONDO_0100096","COVID-19","CHEMBL468","THALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","CUL4A","cullin 4A",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04273581%22,https://clinicaltrials.gov/search?id=%22NCT04273529%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04363827%22,https://clinicaltrials.gov/search?id=%22NCT04336332%22,https://clinicaltrials.gov/search?id=%22NCT04860284%22,https://clinicaltrials.gov/search?id=%22NCT04329832%22,https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04959786%22,https://clinicaltrials.gov/search?id=%22NCT04494399%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFV2","NADH:ubiquinone oxidoreductase core subunit V2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22,https://clinicaltrials.gov/search?id=%22NCT04322396%22,https://clinicaltrials.gov/search?id=%22NCT04373044%22,https://clinicaltrials.gov/search?id=%22NCT04369742%22,https://clinicaltrials.gov/search?id=%22NCT04335552%22,https://clinicaltrials.gov/search?id=%22NCT04358068%22,https://clinicaltrials.gov/search?id=%22NCT04340544%22,https://clinicaltrials.gov/search?id=%22NCT04353271%22,https://clinicaltrials.gov/search?id=%22NCT04605588%22,https://clinicaltrials.gov/search?id=%22NCT04329923%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04359095%22,https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343768%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS2","NADH:ubiquinone oxidoreductase core subunit S2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04482686%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA8","NADH:ubiquinone oxidoreductase subunit A8",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRM1","opioid receptor mu 1",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL672","FENOFIBRATE","Small molecule","Peroxisome proliferator-activated receptor alpha agonist","Agonist","PPARA","peroxisome proliferator activated receptor alpha",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04517396%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4A","phosphodiesterase 4A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE9A","phosphodiesterase 9A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04521400%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4C","phosphodiesterase 4C",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6B","phosphodiesterase 6B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA11","NADH:ubiquinone oxidoreductase subunit A11",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04437693%22,https://clinicaltrials.gov/search?id=%22NCT04354441%22,https://clinicaltrials.gov/search?id=%22NCT04359537%22,https://clinicaltrials.gov/search?id=%22NCT04350450%22,https://clinicaltrials.gov/search?id=%22NCT04712279%22,https://clinicaltrials.gov/search?id=%22NCT04361318%22,https://clinicaltrials.gov/search?id=%22NCT04400019%22"
"MONDO_0100096","COVID-19","CHEMBL4297793","NANGIBOTIDE","Protein","Triggering receptor expressed on myeloid cells 1 inhibitor","Inhibitor","TREM1","triggering receptor expressed on myeloid cells 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04429334%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6H","phosphodiesterase 6H",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354714%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8A","phosphodiesterase 8A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","Equilibrative nucleoside transporter 1 inhibitor","Inhibitor","SLC29A1","solute carrier family 29 member 1 (Augustine blood group)",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1487","ATORVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04466241%22,https://clinicaltrials.gov/search?id=%22NCT04380402%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL1201187","MARAVIROC","Small molecule","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04475991%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARG","retinoic acid receptor gamma",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04396067%22,https://clinicaltrials.gov/search?id=%22NCT04577378%22,https://clinicaltrials.gov/search?id=%22NCT04389580%22,https://clinicaltrials.gov/search?id=%22NCT04578236%22"
"MONDO_0100096","COVID-19","CHEMBL1017","TELMISARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04715763%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN1","glutamate ionotropic receptor NMDA type subunit 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL2040682","CICLESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04330586%22"
"MONDO_0100096","COVID-19","CHEMBL1201149","NALTREXONE HYDROCHLORIDE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRM1","opioid receptor mu 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04708327%22"
"MONDO_0100096","COVID-19","CHEMBL4297680","1018 ISS","Unknown","Toll-like receptor 9 agonist","Agonist","TLR9","toll like receptor 9",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04672395%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04920838%22,https://clinicaltrials.gov/search?id=%22NCT04532931%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","LYN","LYN proto-oncogene, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA9","NADH:ubiquinone oxidoreductase subunit A9",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1201265","METHYLPREDNISOLONE HEMISUCCINATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343729%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF3","NADH:ubiquinone oxidoreductase complex assembly factor 3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04521400%22,https://clinicaltrials.gov/search?id=%22NCT04960202%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1C","phosphodiesterase 1C",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL2103830","FOSTAMATINIB","Small molecule","Tyrosine-protein kinase SYK inhibitor","Inhibitor","SYK","spleen associated tyrosine kinase",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04579393%22"
"MONDO_0100096","COVID-19","CHEMBL148674","VARESPLADIB","Small molecule","Phospholipase A2 group IIA inhibitor","Inhibitor","PLA2G2A","phospholipase A2 group IIA",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04969991%22"
"MONDO_0100096","COVID-19","CHEMBL2108675","DUPILUMAB","Antibody","Interleukin-4 receptor subunit alpha antagonist","Antagonist","IL4R","interleukin 4 receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04920916%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB1","NADH:ubiquinone oxidoreductase subunit B1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL635","PREDNISONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04344288%22"
"MONDO_0100096","COVID-19","CHEMBL38","TRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARB","retinoic acid receptor beta",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04396067%22,https://clinicaltrials.gov/search?id=%22NCT04568096%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE10A","phosphodiesterase 10A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF1","NADH:ubiquinone oxidoreductase complex assembly factor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB5","NADH:ubiquinone oxidoreductase subunit B5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1200969","DUTASTERIDE","Small molecule","Steroid 5-alpha-reductase inhibitor","Inhibitor","SRD5A1","steroid 5 alpha-reductase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04729491%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IL10RB","interleukin 10 receptor subunit beta",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04388709%22"
"MONDO_0100096","COVID-19","CHEMBL2108730","SARILUMAB","Antibody","Interleukin-6 receptor alpha subunit antagonist","Antagonist","IL6R","interleukin 6 receptor",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04324073%22,https://clinicaltrials.gov/search?id=%22NCT04359901%22"
"MONDO_0100096","COVID-19","CHEMBL981","FENOFIBRIC ACID","Small molecule","Peroxisome proliferator-activated receptor alpha agonist","Agonist","PPARA","peroxisome proliferator activated receptor alpha",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04517396%22"
"MONDO_0100096","COVID-19","CHEMBL3707325","LENZILUMAB","Antibody","Granulocyte-macrophage colony-stimulating factor inhibitor","Inhibitor","CSF2","colony stimulating factor 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04583969%22"
"MONDO_0100096","COVID-19","CHEMBL2109343","LERONLIMAB","Antibody","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04347239%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22,https://clinicaltrials.gov/search?id=%22NCT04329923%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7A","phosphodiesterase 7A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1762621","BARDOXOLONE METHYL","Small molecule","Keap1/Nrf2 inhibitor","Inhibitor","NFE2L2","nuclear factor, erythroid 2 like 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04494646%22"
"MONDO_0100096","COVID-19","CHEMBL1201670","SARGRAMOSTIM","Protein","Granulocyte-macrophage colony-stimulating factor receptor agonist","Agonist","CSF2RA","colony stimulating factor 2 receptor subunit alpha",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04411680%22"
"MONDO_0100096","COVID-19","CHEMBL3545347","TXA127","Protein","Proto-oncogene Mas agonist","Agonist","MAS1","MAS1 proto-oncogene, G protein-coupled receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04401423%22,https://clinicaltrials.gov/search?id=%22NCT04605887%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFV2","NADH:ubiquinone oxidoreductase core subunit V2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND4","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL6966","VERAPAMIL","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1C","calcium voltage-gated channel subunit alpha1 C",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351763%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04477993%22,https://clinicaltrials.gov/search?id=%22NCT04366232%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04750317%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04407130%22"
"MONDO_0100096","COVID-19","CHEMBL197194","VIDOFLUDIMUS","Small molecule","Dihydroorotate dehydrogenase inhibitor","Inhibitor","DHODH","dihydroorotate dehydrogenase (quinone)",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04516915%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Vascular endothelial growth factor receptor inhibitor","Inhibitor","FLT4","fms related receptor tyrosine kinase 4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN2A","sodium voltage-gated channel alpha subunit 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B1","guanylate cyclase 1 soluble subunit beta 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT03331445%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04345653%22,https://clinicaltrials.gov/search?id=%22NCT04354870%22,https://clinicaltrials.gov/search?id=%22NCT04333225%22,https://clinicaltrials.gov/search?id=%22NCT04350281%22,https://clinicaltrials.gov/search?id=%22NCT04328961%22,https://clinicaltrials.gov/search?id=%22NCT04343768%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04385264%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04335071%22,https://clinicaltrials.gov/search?id=%22NCT04322773%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343768%22,https://clinicaltrials.gov/search?id=%22NCT04276688%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRM1","opioid receptor mu 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22,https://clinicaltrials.gov/search?id=%22NCT04708327%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN2D","glutamate ionotropic receptor NMDA type subunit 2D",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1C","phosphodiesterase 1C",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL941","IMATINIB","Small molecule","Platelet-derived growth factor receptor beta inhibitor","Inhibitor","PDGFRB","platelet derived growth factor receptor beta",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04346147%22"
"MONDO_0100096","COVID-19","CHEMBL1201149","NALTREXONE HYDROCHLORIDE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRD1","opioid receptor delta 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04708327%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL1201581","INFLIXIMAB","Antibody","TNF-alpha inhibitor","Inhibitor","TNF","tumor necrosis factor",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04425538%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA1B","adrenoceptor alpha 1B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04360096%22,https://clinicaltrials.gov/search?id=%22NCT04488081%22,https://clinicaltrials.gov/search?id=%22NCT04844580%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04920838%22,https://clinicaltrials.gov/search?id=%22NCT04532931%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","Stem cell growth factor receptor inhibitor","Inhibitor","KIT","KIT proto-oncogene, receptor tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA2B","adrenoceptor alpha 2B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04488081%22,https://clinicaltrials.gov/search?id=%22NCT04844580%22,https://clinicaltrials.gov/search?id=%22NCT04360096%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Platelet-derived growth factor receptor inhibitor","Inhibitor","PDGFRA","platelet derived growth factor receptor alpha",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3B","phosphodiesterase 3B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL198362","RIVAROXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04504032%22"
"MONDO_0100096","COVID-19","CHEMBL2108738","NIVOLUMAB","Antibody","Programmed cell death protein 1 inhibitor","Inhibitor","PDCD1","programmed cell death 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04343144%22,https://clinicaltrials.gov/search?id=%22NCT04356508%22"
"MONDO_0100096","COVID-19","CHEMBL3989873","PICLIDENOSON","Small molecule","Adenosine A3 receptor agonist","Agonist","ADORA3","adenosine A3 receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04333472%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA6","NADH:ubiquinone oxidoreductase subunit A6",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA10","NADH:ubiquinone oxidoreductase subunit A10",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFV3","NADH:ubiquinone oxidoreductase subunit V3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1A","melatonin receptor 1A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04568863%22"
"MONDO_0100096","COVID-19","CHEMBL1201202","FONDAPARINUX","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04368377%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04332094%22,https://clinicaltrials.gov/search?id=%22NCT04334512%22,https://clinicaltrials.gov/search?id=%22NCT04387760%22,https://clinicaltrials.gov/search?id=%22NCT04342169%22,https://clinicaltrials.gov/search?id=%22NCT04573153%22,https://clinicaltrials.gov/search?id=%22NCT04366089%22,https://clinicaltrials.gov/search?id=%22NCT04321616%22,https://clinicaltrials.gov/search?id=%22NCT04335084%22,https://clinicaltrials.gov/search?id=%22NCT04318444%22,https://clinicaltrials.gov/search?id=%22NCT04345861%22,https://clinicaltrials.gov/search?id=%22NCT04341870%22,https://clinicaltrials.gov/search?id=%22NCT04351724%22,https://clinicaltrials.gov/search?id=%22NCT04353336%22,https://clinicaltrials.gov/search?id=%22NCT04964583%22,https://clinicaltrials.gov/search?id=%22NCT04395768%22"
"MONDO_0100096","COVID-19","CHEMBL1201583","BEVACIZUMAB","Antibody","Vascular endothelial growth factor A inhibitor","Inhibitor","VEGFA","vascular endothelial growth factor A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04954014%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB4","NADH:ubiquinone oxidoreductase subunit B4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL190461","CANNABIDIOL","Small molecule","Cannabinoid CB1 receptor negative allosteric modulator","Negative allosteric modulator","CNR1","cannabinoid receptor 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04467918%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4C","phosphodiesterase 4C",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB7","NADH:ubiquinone oxidoreductase subunit B7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IFNLR1","interferon lambda receptor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04354259%22,https://clinicaltrials.gov/search?id=%22NCT04344600%22,https://clinicaltrials.gov/search?id=%22NCT04534673%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA4L2","NDUFA4 mitochondrial complex associated like 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","Platelet-derived growth factor receptor beta inhibitor","Inhibitor","PDGFRB","platelet derived growth factor receptor beta",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","LCK","LCK proto-oncogene, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFC2","NADH:ubiquinone oxidoreductase subunit C2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04360876%22"
"MONDO_0100096","COVID-19","CHEMBL650","METHYLPREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04323592%22,https://clinicaltrials.gov/search?id=%22NCT04329650%22,https://clinicaltrials.gov/search?id=%22NCT04355247%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL4297734","CRIZANLIZUMAB","Antibody","P-selectin blocker","Blocker","SELP","selectin P",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04435184%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR2","fibroblast growth factor receptor 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL197194","VIDOFLUDIMUS","Small molecule","Dihydroorotate dehydrogenase inhibitor","Inhibitor","DHODH","dihydroorotate dehydrogenase (quinone)",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04379271%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04340232%22"
"MONDO_0100096","COVID-19","CHEMBL2109617","HUMAX-IL8","Antibody","Interleukin-8 inhibitor","Inhibitor","CXCL8","C-X-C motif chemokine ligand 8",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04347226%22"
"MONDO_0100096","COVID-19","CHEMBL1237022","TOCILIZUMAB","Antibody","Interleukin-6 receptor alpha subunit inhibitor","Inhibitor","IL6R","interleukin 6 receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04479358%22,https://clinicaltrials.gov/search?id=%22NCT04346355%22,https://clinicaltrials.gov/search?id=%22NCT04332094%22,https://clinicaltrials.gov/search?id=%22NCT04335305%22,https://clinicaltrials.gov/search?id=%22NCT04412291%22"
"MONDO_0100096","COVID-19","CHEMBL3707247","OZANIMOD","Small molecule","Sphingosine 1-phosphate receptor Edg-1 modulator","Modulator","S1PR1","sphingosine-1-phosphate receptor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04405102%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6C","phosphodiesterase 6C",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRK1","opioid receptor kappa 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04708327%22,https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL3039502","DUVELISIB","Small molecule","PI3-kinase p110-gamma subunit inhibitor","Inhibitor","PIK3CG","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04487886%22,https://clinicaltrials.gov/search?id=%22NCT04372602%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7B","phosphodiesterase 7B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL495","ALPROSTADIL","Small molecule","Prostanoid EP2 receptor agonist","Agonist","PTGER2","prostaglandin E receptor 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04536363%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04407130%22,https://clinicaltrials.gov/search?id=%22NCT04349410%22"
"MONDO_0100096","COVID-19","CHEMBL1743071","SIRUKUMAB","Antibody","Interleukin-6 inhibitor","Inhibitor","IL6","interleukin 6",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04380961%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA1A","adrenoceptor alpha 1A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04488081%22,https://clinicaltrials.gov/search?id=%22NCT04844580%22,https://clinicaltrials.gov/search?id=%22NCT04360096%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04459702%22"
"MONDO_0100096","COVID-19","CHEMBL314854","FINGOLIMOD","Small molecule","Sphingosine 1-phosphate receptor agonist","Agonist","S1PR4","sphingosine-1-phosphate receptor 4",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04280588%22"
"MONDO_0100096","COVID-19","CHEMBL633","AMIODARONE","Small molecule","HERG blocker","Blocker","KCNH2","potassium voltage-gated channel subfamily H member 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351763%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF4","NADH:ubiquinone oxidoreductase complex assembly factor 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN2A","glutamate ionotropic receptor NMDA type subunit 2A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","FRK","fyn related Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND5","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1042","CHOLECALCIFEROL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04400890%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04332042%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B2","guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT03331445%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN3A","sodium voltage-gated channel alpha subunit 3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04385095%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAB1","NADH:ubiquinone oxidoreductase subunit AB1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1230314","ESTETROL","Small molecule","Estrogen receptor agonist","Agonist","ESR1","estrogen receptor 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04801836%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE2A","phosphodiesterase 2A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1393","SPIRONOLACTONE","Small molecule","Mineralocorticoid receptor antagonist","Antagonist","NR3C2","nuclear receptor subfamily 3 group C member 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04643691%22"
"MONDO_0100096","COVID-19","CHEMBL3545185","SELINEXOR","Small molecule","Exportin-1 inhibitor","Inhibitor","XPO1","exportin 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349098%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS5","NADH:ubiquinone oxidoreductase subunit S5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CB","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit beta",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL1201823","ABATACEPT","Protein","T-lymphocyte activation antigen CD80 inhibitor","Inhibitor","CD80","CD80 molecule",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04472494%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL3137343","PEMBROLIZUMAB","Antibody","Programmed cell death protein 1 inhibitor","Inhibitor","PDCD1","programmed cell death 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04335305%22"
"MONDO_0100096","COVID-19","CHEMBL314854","FINGOLIMOD","Small molecule","Sphingosine 1-phosphate receptor agonist","Agonist","S1PR3","sphingosine-1-phosphate receptor 3",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04280588%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04338958%22,https://clinicaltrials.gov/search?id=%22NCT04348695%22"
"MONDO_0100096","COVID-19","CHEMBL429910","DAPAGLIFLOZIN","Small molecule","Sodium/glucose cotransporter 2 inhibitor","Inhibitor","SLC5A2","solute carrier family 5 member 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04393246%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL1201562","INTERFERON BETA-1A","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04330690%22,https://clinicaltrials.gov/search?id=%22NCT04518410%22"
"MONDO_0100096","COVID-19","CHEMBL1496","ROSUVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04359095%22"
"MONDO_0100096","COVID-19","CHEMBL1651956","ALISPORIVIR","Protein","Cyclophilin A inhibitor","Inhibitor","PPIA","peptidylprolyl isomerase A",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04608214%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA4L2","NDUFA4 mitochondrial complex associated like 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1743039","MAVRILIMUMAB","Antibody","Granulocyte-macrophage colony-stimulating factor receptor antagonist","Antagonist","CSF2RA","colony stimulating factor 2 receptor subunit alpha",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04447469%22"
"MONDO_0100096","COVID-19","CHEMBL3039502","DUVELISIB","Small molecule","PI3-kinase p110-delta subunit inhibitor","Inhibitor","PIK3CD","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04487886%22,https://clinicaltrials.gov/search?id=%22NCT04372602%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA4","NDUFA4 mitochondrial complex associated",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND4L","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL4297865","ABIVERTINIB","Small molecule","Epidermal growth factor receptor erbB1 inhibitor","Inhibitor","EGFR","epidermal growth factor receptor",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04440007%22"
"MONDO_0100096","COVID-19","CHEMBL1230314","ESTETROL","Small molecule","Estrogen receptor agonist","Agonist","ESR2","estrogen receptor 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04801836%22"
"MONDO_0100096","COVID-19","CHEMBL1873475","IBRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04665115%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS7","NADH:ubiquinone oxidoreductase core subunit S7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL495","ALPROSTADIL","Small molecule","Prostanoid EP1 receptor agonist","Agonist","PTGER1","prostaglandin E receptor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04536363%22"
"MONDO_0100096","COVID-19","CHEMBL2110727","CENICRIVIROC","Small molecule","C-C chemokine receptor type 2 antagonist","Antagonist","CCR2","C-C motif chemokine receptor 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04500418%22"
"MONDO_0100096","COVID-19","CHEMBL1064","SIMVASTATIN","Small molecule","HMG-CoA reductase inhibitor","Inhibitor","HMGCR","3-hydroxy-3-methylglutaryl-CoA reductase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04348695%22"
"MONDO_0100096","COVID-19","CHEMBL413","SIROLIMUS","Small molecule","FK506-binding protein 1A inhibitor","Inhibitor","FKBP1A","FKBP prolyl isomerase 1A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04341675%22,https://clinicaltrials.gov/search?id=%22NCT04461340%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","YES1","YES proto-oncogene 1, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND2","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRD1","opioid receptor delta 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22,https://clinicaltrials.gov/search?id=%22NCT04604704%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04603742%22"
"MONDO_0100096","COVID-19","CHEMBL4298195","NARSOPLIMAB","Antibody","Mannan-binding lectin serine protease 2 inhibitor","Inhibitor","MASP2","MBL associated serine protease 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","Bcr/Abl fusion protein","Inhibitor","BCR","BCR activator of RhoGEF and GTPase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1908391","MASITINIB","Small molecule","Stem cell growth factor receptor inhibitor","Inhibitor","KIT","KIT proto-oncogene, receptor tyrosine kinase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04622865%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","Serine/threonine-protein kinase mTOR inhibitor","Inhibitor","MTOR","mechanistic target of rapamycin kinase",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND3","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL2393130","APABETALONE","Small molecule","Bromodomain and extra-terminal motif (BET) inhibitor","Inhibitor","BRD2","bromodomain containing 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894266%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7A","phosphodiesterase 7A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL786","TAMOXIFEN CITRATE","Small molecule","Estrogen receptor alpha modulator","Modulator","ESR1","estrogen receptor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04568096%22,https://clinicaltrials.gov/search?id=%22NCT04389580%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04407130%22"
"MONDO_0100096","COVID-19","CHEMBL2","PRAZOSIN","Small molecule","Adrenergic receptor alpha-1 antagonist","Antagonist","ADRA1D","adrenoceptor alpha 1D",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365257%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415151%22"
"MONDO_0100096","COVID-19","CHEMBL1201558","INTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22"
"MONDO_0100096","COVID-19","CHEMBL3989798","FORMOTEROL FUMARATE","Small molecule","Beta-2 adrenergic receptor agonist","Agonist","ADRB2","adrenoceptor beta 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04937543%22"
"MONDO_0100096","COVID-19","CHEMBL44657","ETOPOSIDE","Small molecule","DNA topoisomerase II inhibitor","Inhibitor","TOP2B","DNA topoisomerase II beta",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04356690%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN4A","sodium voltage-gated channel alpha subunit 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS8","NADH:ubiquinone oxidoreductase core subunit S8",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04501965%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04960202%22,https://clinicaltrials.gov/search?id=%22NCT04521400%22"
"MONDO_0100096","COVID-19","CHEMBL2109636","VILOBELIMAB","Antibody","Complement C5 inhibitor","Inhibitor","C5","complement C5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04333420%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB3","NADH:ubiquinone oxidoreductase subunit B3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN3B","glutamate ionotropic receptor NMDA type subunit 3B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04339712%22,https://clinicaltrials.gov/search?id=%22NCT04341584%22,https://clinicaltrials.gov/search?id=%22NCT04443881%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8B","phosphodiesterase 8B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04964583%22,https://clinicaltrials.gov/search?id=%22NCT04366089%22,https://clinicaltrials.gov/search?id=%22NCT04351724%22,https://clinicaltrials.gov/search?id=%22NCT04342169%22,https://clinicaltrials.gov/search?id=%22NCT04321616%22,https://clinicaltrials.gov/search?id=%22NCT04345861%22,https://clinicaltrials.gov/search?id=%22NCT04353336%22,https://clinicaltrials.gov/search?id=%22NCT04573153%22,https://clinicaltrials.gov/search?id=%22NCT04341870%22,https://clinicaltrials.gov/search?id=%22NCT04387760%22,https://clinicaltrials.gov/search?id=%22NCT04332094%22,https://clinicaltrials.gov/search?id=%22NCT04334512%22,https://clinicaltrials.gov/search?id=%22NCT04395768%22,https://clinicaltrials.gov/search?id=%22NCT04318444%22,https://clinicaltrials.gov/search?id=%22NCT04335084%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Platelet-derived growth factor receptor inhibitor","Inhibitor","PDGFRB","platelet derived growth factor receptor beta",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","SRMS","src-related kinase lacking C-terminal regulatory tyrosine and N-terminal myristylation sites",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL1370","BUDESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04331470%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA2","NADH:ubiquinone oxidoreductase subunit A2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL6966","VERAPAMIL","Small molecule","Voltage-gated L-type calcium channel blocker","Blocker","CACNA1S","calcium voltage-gated channel subunit alpha1 S",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04351763%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4D","phosphodiesterase 4D",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6A","phosphodiesterase 6A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4B","phosphodiesterase 4B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04368377%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","Tyrosine-protein kinase ABL inhibitor","Inhibitor","ABL1","ABL proto-oncogene 1, non-receptor tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL814","FLUVOXAMINE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04342663%22"
"MONDO_0100096","COVID-19","CHEMBL1201081","METHYLPREDNISOLONE SODIUM SUCCINATE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343729%22"
"MONDO_0100096","COVID-19","CHEMBL4081711","PF-06650833","Small molecule","Interleukin-1 receptor-associated kinase 4 inhibitor","Inhibitor","IRAK4","interleukin 1 receptor associated kinase 4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04575610%22,https://clinicaltrials.gov/search?id=%22NCT04933799%22"
"MONDO_0100096","COVID-19","CHEMBL1200969","DUTASTERIDE","Small molecule","Steroid 5-alpha-reductase inhibitor","Inhibitor","SRD5A3","steroid 5 alpha-reductase 3",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04729491%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04328961%22,https://clinicaltrials.gov/search?id=%22NCT04345653%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL1201583","BEVACIZUMAB","Antibody","Vascular endothelial growth factor A inhibitor","Inhibitor","VEGFA","vascular endothelial growth factor A",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04344782%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CA","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit alpha",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","Ephrin type-A receptor 2 inhibitor","Inhibitor","EPHA2","EPH receptor A2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL787","MONTELUKAST","Small molecule","Cysteinyl leukotriene receptor 1 antagonist","Antagonist","CYSLTR1","cysteinyl leukotriene receptor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04718285%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA12","NADH:ubiquinone oxidoreductase subunit A12",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARA","retinoic acid receptor alpha",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04396067%22,https://clinicaltrials.gov/search?id=%22NCT04389580%22,https://clinicaltrials.gov/search?id=%22NCT04577378%22,https://clinicaltrials.gov/search?id=%22NCT04578236%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IL10RB","interleukin 10 receptor subunit beta",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04343976%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA1","NADH:ubiquinone oxidoreductase subunit A1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1B","melatonin receptor 1B",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04531748%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF2","NADH:ubiquinone oxidoreductase complex assembly factor 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1111","AMBRISENTAN","Small molecule","Endothelin receptor, ET-A/ET-B antagonist","Antagonist","EDNRA","endothelin receptor type A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04393246%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1A","melatonin receptor 1A",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04353128%22"
"MONDO_0100096","COVID-19","CHEMBL1908391","MASITINIB","Small molecule","Platelet-derived growth factor receptor inhibitor","Inhibitor","PDGFRB","platelet derived growth factor receptor beta",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04622865%22"
"MONDO_0100096","COVID-19","CHEMBL650","METHYLPREDNISOLONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04244591%22"
"MONDO_0100096","COVID-19","CHEMBL1218","RAMELTEON","Small molecule","Melatonin receptor agonist","Agonist","MTNR1B","melatonin receptor 1B",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04470297%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1201563","INTERFERON BETA-1B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04647695%22,https://clinicaltrials.gov/search?id=%22NCT04494399%22,https://clinicaltrials.gov/search?id=%22NCT04356495%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA2C","adrenoceptor alpha 2C",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04844580%22,https://clinicaltrials.gov/search?id=%22NCT04360096%22,https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL415606","DEGARELIX","Protein","Gonadotropin-releasing hormone receptor antagonist","Antagonist","GNRHR","gonadotropin releasing hormone receptor",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04397718%22"
"MONDO_0100096","COVID-19","CHEMBL1200969","DUTASTERIDE","Small molecule","Steroid 5-alpha-reductase inhibitor","Inhibitor","SRD5A2","steroid 5 alpha-reductase 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04729491%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL191","LOSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22,https://clinicaltrials.gov/search?id=%22NCT04311177%22,https://clinicaltrials.gov/search?id=%22NCT04312009%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04358614%22"
"MONDO_0100096","COVID-19","CHEMBL1230165","SILMITASERTIB","Small molecule","Casein kinase II alpha inhibitor","Inhibitor","CSNK2A1","casein kinase 2 alpha 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04668209%22,https://clinicaltrials.gov/search?id=%22NCT04663737%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","HCK","HCK proto-oncogene, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL964","DISULFIRAM","Small molecule","Aldehyde dehydrogenase inhibitor","Inhibitor","ALDH2","aldehyde dehydrogenase 2 family member",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04485130%22,https://clinicaltrials.gov/search?id=%22NCT04594343%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B2","guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04312243%22,https://clinicaltrials.gov/search?id=%22NCT04388683%22,https://clinicaltrials.gov/search?id=%22NCT04306393%22,https://clinicaltrials.gov/search?id=%22NCT04305457%22,https://clinicaltrials.gov/search?id=%22NCT04338828%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R5","phosphoinositide-3-kinase regulatory subunit 5",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL2108730","SARILUMAB","Antibody","Interleukin-6 receptor alpha subunit antagonist","Antagonist","IL6R","interleukin 6 receptor",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04357808%22,https://clinicaltrials.gov/search?id=%22NCT04315298%22,https://clinicaltrials.gov/search?id=%22NCT04357860%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04937088%22,https://clinicaltrials.gov/search?id=%22NCT04363840%22"
"MONDO_0100096","COVID-19","CHEMBL1201335","GLYCOPYRRONIUM","Small molecule","Muscarinic acetylcholine receptor M3 antagonist","Antagonist","CHRM3","cholinergic receptor muscarinic 3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04937543%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04354428%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04459286%22,https://clinicaltrials.gov/search?id=%22NCT04331470%22,https://clinicaltrials.gov/search?id=%22NCT04466241%22,https://clinicaltrials.gov/search?id=%22NCT04499677%22,https://clinicaltrials.gov/search?id=%22NCT04372628%22,https://clinicaltrials.gov/search?id=%22NCT04351724%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04521400%22,https://clinicaltrials.gov/search?id=%22NCT04960202%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04340232%22"
"MONDO_0100096","COVID-19","CHEMBL877","TRANEXAMIC ACID","Small molecule","Plasminogen inhibitor","Inhibitor","PLG","plasminogen",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04390217%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE9A","phosphodiesterase 9A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IL10RB","interleukin 10 receptor subunit beta",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04331899%22"
"MONDO_0100096","COVID-19","CHEMBL2110727","CENICRIVIROC","Small molecule","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04500418%22"
"MONDO_0100096","COVID-19","CHEMBL2028850","ICATIBANT","Protein","Bradykinin B2 receptor antagonist","Antagonist","BDKRB2","bradykinin receptor B2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04978051%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFC2","NADH:ubiquinone oxidoreductase subunit C2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1201563","INTERFERON BETA-1B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04647695%22,https://clinicaltrials.gov/search?id=%22NCT04494399%22,https://clinicaltrials.gov/search?id=%22NCT04356495%22"
"MONDO_0100096","COVID-19","CHEMBL1017","TELMISARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04920838%22,https://clinicaltrials.gov/search?id=%22NCT04356495%22,https://clinicaltrials.gov/search?id=%22NCT04466241%22,https://clinicaltrials.gov/search?id=%22NCT04360551%22"
"MONDO_0100096","COVID-19","CHEMBL1201828","ECULIZUMAB","Antibody","Complement C5 inhibitor","Inhibitor","C5","complement C5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04346797%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04328961%22,https://clinicaltrials.gov/search?id=%22NCT04345653%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL3936761","ZANUBRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04382586%22"
"MONDO_0100096","COVID-19","CHEMBL468","THALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","RBX1","ring-box 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04273529%22,https://clinicaltrials.gov/search?id=%22NCT04273581%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB11","NADH:ubiquinone oxidoreductase subunit B11",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04407130%22,https://clinicaltrials.gov/search?id=%22NCT04349410%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04469114%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04344756%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04482686%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1A","phosphodiesterase 1A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF3","NADH:ubiquinone oxidoreductase complex assembly factor 3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK3","Janus kinase 3",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04469114%22"
"MONDO_0100096","COVID-19","CHEMBL1771","CLOPIDOGREL","Small molecule","Purinergic receptor P2Y12 antagonist","Antagonist","P2RY12","purinergic receptor P2Y12",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04368377%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04469114%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK3","Janus kinase 3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415151%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IFNLR1","interferon lambda receptor 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04388709%22"
"MONDO_0100096","COVID-19","CHEMBL1200973","ESTRADIOL CYPIONATE","Small molecule","Estrogen receptor alpha agonist","Agonist","ESR1","estrogen receptor 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04865029%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CG","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit gamma",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04482686%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6D","phosphodiesterase 6D",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB4","NADH:ubiquinone oxidoreductase subunit B4",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1168","RAMIPRIL","Small molecule","Angiotensin-converting enzyme inhibitor","Inhibitor","ACE","angiotensin I converting enzyme",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04366050%22"
"MONDO_0100096","COVID-19","CHEMBL1201414","TINZAPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04808882%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IFNLR1","interferon lambda receptor 1",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04343976%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN11A","sodium voltage-gated channel alpha subunit 11",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL4297442","TD-139","Small molecule","Galectin-3 inhibitor","Inhibitor","LGALS3","galectin 3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04473053%22"
"MONDO_0100096","COVID-19","CHEMBL3989977","EMAPALUMAB","Antibody","Interferon gamma inhibitor","Inhibitor","IFNG","interferon gamma",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04324021%22"
"MONDO_0100096","COVID-19","CHEMBL1743039","MAVRILIMUMAB","Antibody","Granulocyte-macrophage colony-stimulating factor receptor antagonist","Antagonist","CSF2RB","colony stimulating factor 2 receptor subunit beta",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04447469%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A5","cytochrome P450 family 3 subfamily A member 5",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04459702%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS1","NADH:ubiquinone oxidoreductase core subunit S1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354714%22"
"MONDO_0100096","COVID-19","CHEMBL1201558","INTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04349410%22"
"MONDO_0100096","COVID-19","CHEMBL1908391","MASITINIB","Small molecule","Platelet-derived growth factor receptor inhibitor","Inhibitor","PDGFRA","platelet derived growth factor receptor alpha",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04622865%22"
"MONDO_0100096","COVID-19","CHEMBL38","TRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARA","retinoic acid receptor alpha",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04568096%22,https://clinicaltrials.gov/search?id=%22NCT04396067%22"
"MONDO_0100096","COVID-19","CHEMBL314854","FINGOLIMOD","Small molecule","Sphingosine 1-phosphate receptor agonist","Agonist","S1PR5","sphingosine-1-phosphate receptor 5",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04280588%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR3","fibroblast growth factor receptor 3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Fibroblast growth factor receptor inhibitor","Inhibitor","FGFR1","fibroblast growth factor receptor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6D","phosphodiesterase 6D",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL1201561","PEGINTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04480138%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04374552%22,https://clinicaltrials.gov/search?id=%22NCT04389359%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6G","phosphodiesterase 6G",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRD1","opioid receptor delta 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04708327%22,https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","TYK2","tyrosine kinase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04415151%22"
"MONDO_0100096","COVID-19","CHEMBL313006","DALCETRAPIB","Small molecule","Cholesteryl ester transfer protein inhibitor","Inhibitor","CETP","cholesteryl ester transfer protein",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04676867%22"
"MONDO_0100096","COVID-19","CHEMBL3545347","TXA127","Protein","Proto-oncogene Mas agonist","Agonist","MAS1","MAS1 proto-oncogene, G protein-coupled receptor",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04924660%22,https://clinicaltrials.gov/search?id=%22NCT04332666%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6G","phosphodiesterase 6G",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04338958%22,https://clinicaltrials.gov/search?id=%22NCT04348695%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04459286%22,https://clinicaltrials.gov/search?id=%22NCT04466241%22,https://clinicaltrials.gov/search?id=%22NCT04331470%22,https://clinicaltrials.gov/search?id=%22NCT04372628%22,https://clinicaltrials.gov/search?id=%22NCT04351724%22,https://clinicaltrials.gov/search?id=%22NCT04499677%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04359290%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04365309%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND5","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL384467","DEXAMETHASONE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04513184%22"
"MONDO_0100096","COVID-19","CHEMBL83","TAMOXIFEN","Small molecule","Estrogen receptor alpha modulator","Modulator","ESR1","estrogen receptor 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04568096%22,https://clinicaltrials.gov/search?id=%22NCT04389580%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343768%22,https://clinicaltrials.gov/search?id=%22NCT04276688%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04348071%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA7","NADH:ubiquinone oxidoreductase subunit A7",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1218","RAMELTEON","Small molecule","Melatonin receptor agonist","Agonist","MTNR1A","melatonin receptor 1A",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04470297%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IL10RB","interleukin 10 receptor subunit beta",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04534673%22,https://clinicaltrials.gov/search?id=%22NCT04344600%22,https://clinicaltrials.gov/search?id=%22NCT04354259%22"
"MONDO_0100096","COVID-19","CHEMBL4297643","APILIMOD","Small molecule","1-phosphatidylinositol 3-phosphate 5-kinase inhibitor","Inhibitor","PIKFYVE","phosphoinositide kinase, FYVE-type zinc finger containing",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04446377%22"
"MONDO_0100096","COVID-19","CHEMBL742","KETAMINE","Small molecule","Glutamate [NMDA] receptor negative allosteric modulator","Negative allosteric modulator","GRIN2B","glutamate ionotropic receptor NMDA type subunit 2B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE2A","phosphodiesterase 2A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1201561","PEGINTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04480138%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04369742%22,https://clinicaltrials.gov/search?id=%22NCT04605588%22,https://clinicaltrials.gov/search?id=%22NCT04340544%22,https://clinicaltrials.gov/search?id=%22NCT04322396%22,https://clinicaltrials.gov/search?id=%22NCT04373044%22,https://clinicaltrials.gov/search?id=%22NCT04329923%22,https://clinicaltrials.gov/search?id=%22NCT04353271%22,https://clinicaltrials.gov/search?id=%22NCT04335552%22,https://clinicaltrials.gov/search?id=%22NCT04358068%22,https://clinicaltrials.gov/search?id=%22NCT04307693%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","Serine/threonine-protein kinase mTOR inhibitor","Inhibitor","MTOR","mechanistic target of rapamycin kinase",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04433078%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB10","NADH:ubiquinone oxidoreductase subunit B10",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A7","cytochrome P450 family 3 subfamily A member 7",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04343768%22,https://clinicaltrials.gov/search?id=%22NCT04276688%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04332042%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE10A","phosphodiesterase 10A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA12","NADH:ubiquinone oxidoreductase subunit A12",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFAF2","NADH:ubiquinone oxidoreductase complex assembly factor 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6B","phosphodiesterase 6B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04363840%22,https://clinicaltrials.gov/search?id=%22NCT04937088%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8A","phosphodiesterase 8A",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL4297455","AT-001","Small molecule","Aldose reductase inhibitor","Inhibitor","AKR1B1","aldo-keto reductase family 1 member B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04365699%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN10A","sodium voltage-gated channel alpha subunit 10",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL3989798","FORMOTEROL FUMARATE","Small molecule","Beta-2 adrenergic receptor agonist","Agonist","ADRB2","adrenoceptor beta 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04331470%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS6","NADH:ubiquinone oxidoreductase subunit S6",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS1","NADH:ubiquinone oxidoreductase core subunit S1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04368377%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04466670%22,https://clinicaltrials.gov/search?id=%22NCT04635241%22,https://clinicaltrials.gov/search?id=%22NCT04655586%22,https://clinicaltrials.gov/search?id=%22NCT04842292%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB6","NADH:ubiquinone oxidoreductase subunit B6",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B1","guanylate cyclase 1 soluble subunit beta 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04337918%22"
"MONDO_0100096","COVID-19","CHEMBL2109330","IC14","Antibody","Monocyte differentiation antigen CD14 inhibitor","Inhibitor","CD14","CD14 molecule",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04488081%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS6","NADH:ubiquinone oxidoreductase subunit S6",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN5A","sodium voltage-gated channel alpha subunit 5",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6C","phosphodiesterase 6C",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22,https://clinicaltrials.gov/search?id=%22NCT04329923%22"
"MONDO_0100096","COVID-19","CHEMBL1743050","OLOKIZUMAB","Antibody","Interleukin-6 inhibitor","Inhibitor","IL6","interleukin 6",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04380519%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04724720%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3A","phosphodiesterase 3A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1B","phosphodiesterase 1B",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL2108589","CLAZAKIZUMAB","Antibody","Interleukin-6 inhibitor","Inhibitor","IL6","interleukin 6",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04348500%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND6","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 6",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1201570","ANAKINRA","Protein","Interleukin-1 receptor antagonist","Antagonist","IL1R1","interleukin 1 receptor type 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04462757%22,https://clinicaltrials.gov/search?id=%22NCT04366232%22,https://clinicaltrials.gov/search?id=%22NCT04324021%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22"
"MONDO_0100096","COVID-19","CHEMBL1201670","SARGRAMOSTIM","Protein","Granulocyte-macrophage colony-stimulating factor receptor agonist","Agonist","CSF2RA","colony stimulating factor 2 receptor subunit alpha",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04707664%22,https://clinicaltrials.gov/search?id=%22NCT04642950%22"
"MONDO_0100096","COVID-19","CHEMBL2109377","PAMREVLUMAB","Antibody","Connective tissue growth factor inhibitor","Inhibitor","CCN2","cellular communication network factor 2",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04432298%22"
"MONDO_0100096","COVID-19","CHEMBL502835","NINTEDANIB","Small molecule","Vascular endothelial growth factor receptor inhibitor","Inhibitor","KDR","kinase insert domain receptor",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04338802%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04466670%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04375202%22,https://clinicaltrials.gov/search?id=%22NCT04322565%22,https://clinicaltrials.gov/search?id=%22NCT04359095%22,https://clinicaltrials.gov/search?id=%22NCT04492358%22,https://clinicaltrials.gov/search?id=%22NCT04363437%22,https://clinicaltrials.gov/search?id=%22NCT04360980%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL79","LIDOCAINE","Small molecule","Sodium channel alpha subunit blocker","Blocker","SCN8A","sodium voltage-gated channel alpha subunit 8",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04901065%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","TYK2","tyrosine kinase 2",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04332042%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B1","guanylate cyclase 1 soluble subunit beta 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04290858%22,https://clinicaltrials.gov/search?id=%22NCT04290871%22"
"MONDO_0100096","COVID-19","CHEMBL198362","RIVAROXABAN","Small molecule","Coagulation factor X inhibitor","Inhibitor","F10","coagulation factor X",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04640181%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04551755%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRK1","opioid receptor kappa 1",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Vanilloid receptor opener","Opener","TRPV1","transient receptor potential cation channel subfamily V member 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04532931%22,https://clinicaltrials.gov/search?id=%22NCT04920838%22"
"MONDO_0100096","COVID-19","CHEMBL1421","DASATINIB","Small molecule","SRC inhibitor","Inhibitor","BLK","BLK proto-oncogene, Src family tyrosine kinase",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04830735%22"
"MONDO_0100096","COVID-19","CHEMBL941","IMATINIB","Small molecule","Bcr/Abl fusion protein","Inhibitor","ABL1","ABL proto-oncogene 1, non-receptor tyrosine kinase",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04346147%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04326790%22"
"MONDO_0100096","COVID-19","CHEMBL468","THALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","DDB1","damage specific DNA binding protein 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04273529%22,https://clinicaltrials.gov/search?id=%22NCT04273581%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND3","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 3",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04412252%22"
"MONDO_0100096","COVID-19","CHEMBL1743070","SILTUXIMAB","Antibody","Interleukin-6 inhibitor","Antagonist","IL6","interleukin 6",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04329650%22"
"MONDO_0100096","COVID-19","CHEMBL1111","AMBRISENTAN","Small molecule","Endothelin receptor, ET-A/ET-B antagonist","Antagonist","EDNRB","endothelin receptor type B",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04393246%22"
"MONDO_0100096","COVID-19","CHEMBL19019","NALTREXONE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRM1","opioid receptor mu 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04604704%22,https://clinicaltrials.gov/search?id=%22NCT04365985%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1115","PYRIDOSTIGMINE","Small molecule","Acetylcholinesterase inhibitor","Inhibitor","ACHE","acetylcholinesterase (Cartwright blood group)",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04343963%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3R2","phosphoinositide-3-kinase regulatory subunit 2",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA13","NADH:ubiquinone oxidoreductase subunit A13",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL45","MELATONIN","Small molecule","Melatonin receptor agonist","Agonist","MTNR1A","melatonin receptor 1A",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04531748%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04374149%22"
"MONDO_0100096","COVID-19","CHEMBL1040","CALCIFEDIOL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04366908%22"
"MONDO_0100096","COVID-19","CHEMBL221959","TOFACITINIB","Small molecule","Janus Kinase (JAK) inhibitor","Inhibitor","TYK2","tyrosine kinase 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04750317%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04321993%22,https://clinicaltrials.gov/search?id=%22NCT04891133%22,https://clinicaltrials.gov/search?id=%22NCT04346147%22"
"MONDO_0100096","COVID-19","CHEMBL2109430","GIMSILUMAB","Antibody","Granulocyte-macrophage colony-stimulating factor inhibitor","Inhibitor","CSF2","colony stimulating factor 2",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04351243%22"
"MONDO_0100096","COVID-19","CHEMBL25","ASPIRIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04365309%22"
"MONDO_0100096","COVID-19","CHEMBL1762621","BARDOXOLONE METHYL","Small molecule","Inhibitor of nuclear factor kappa B kinase beta subunit inhibitor","Inhibitor","IKBKB","inhibitor of nuclear factor kappa B kinase subunit beta",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04494646%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CD","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04409327%22"
"MONDO_0100096","COVID-19","CHEMBL2393130","APABETALONE","Small molecule","Bromodomain and extra-terminal motif (BET) inhibitor","Inhibitor","BRD4","bromodomain containing 4",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04894266%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND1","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 1",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL3544909","CALCIFEDIOL","Small molecule","Vitamin D receptor agonist","Agonist","VDR","vitamin D receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04366908%22"
"MONDO_0100096","COVID-19","CHEMBL1879463","DACTOLISIB","Small molecule","PI3-kinase class I inhibitor","Inhibitor","PIK3CD","phosphatidylinositol-4,5-bisphosphate 3-kinase catalytic subunit delta",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04584710%22"
"MONDO_0100096","COVID-19","CHEMBL2106041","AVIPTADIL","Protein","Adrenergic receptor alpha antagonist","Antagonist","ADRA2A","adrenoceptor alpha 2A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04360096%22,https://clinicaltrials.gov/search?id=%22NCT04488081%22,https://clinicaltrials.gov/search?id=%22NCT04844580%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",2,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04355143%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B2","guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04290871%22,https://clinicaltrials.gov/search?id=%22NCT04290858%22"
"MONDO_0100096","COVID-19","CHEMBL2108723","PEGINTERFERON LAMBDA-1A","Protein","Interferon lambda receptor agonist","Agonist","IFNLR1","interferon lambda receptor 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04331899%22"
"MONDO_0100096","COVID-19","CHEMBL1201834","CANAKINUMAB","Antibody","Interleukin-1 beta inhibitor","Inhibitor","IL1B","interleukin 1 beta",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04365153%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB8","NADH:ubiquinone oxidoreductase subunit B8",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1A","phosphodiesterase 1A",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARB","retinoic acid receptor beta",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04577378%22,https://clinicaltrials.gov/search?id=%22NCT04396067%22,https://clinicaltrials.gov/search?id=%22NCT04578236%22,https://clinicaltrials.gov/search?id=%22NCT04389580%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB1","NADH:ubiquinone oxidoreductase subunit B1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04867226%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04367168%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04407130%22,https://clinicaltrials.gov/search?id=%22NCT04349410%22"
"MONDO_0100096","COVID-19","CHEMBL468","THALIDOMIDE","Small molecule","CRL4(CRBN) E3 ubiquitin ligase inhibitor","Inhibitor","CRBN","cereblon",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04273581%22,https://clinicaltrials.gov/search?id=%22NCT04273529%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFA11","NADH:ubiquinone oxidoreductase subunit A11",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A4","cytochrome P450 family 3 subfamily A member 4",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04459702%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFB3","NADH:ubiquinone oxidoreductase subunit B3",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04510194%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","Equilibrative nucleoside transporter 1 inhibitor","Inhibitor","SLC29A1","solute carrier family 29 member 1 (Augustine blood group)",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04391179%22"
"MONDO_0100096","COVID-19","CHEMBL932","DIPYRIDAMOLE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4D","phosphodiesterase 4D",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04424901%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",2,"Enrolling by invitation","https://clinicaltrials.gov/search?id=%22NCT04756128%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","NDUFS7","NADH:ubiquinone oxidoreductase core subunit S7",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL877","TRANEXAMIC ACID","Small molecule","Plasminogen inhibitor","Inhibitor","PLG","plasminogen",2,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04338126%22"
"MONDO_0100096","COVID-19","CHEMBL2105759","BARICITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04320277%22"
"MONDO_0100096","COVID-19","CHEMBL103","PROGESTERONE","Small molecule","Progesterone receptor agonist","Agonist","PGR","progesterone receptor",2,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04865029%22"
"MONDO_0100096","COVID-19","CHEMBL1201149","NALTREXONE HYDROCHLORIDE","Small molecule","Opioid receptors; mu/kappa/delta antagonist","Antagonist","OPRK1","opioid receptor kappa 1",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04708327%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",2,"Completed","https://clinicaltrials.gov/search?id=%22NCT04407130%22,https://clinicaltrials.gov/search?id=%22NCT04349410%22"
"MONDO_0100096","COVID-19","CHEMBL163","RITONAVIR","Small molecule","Cytochrome P450 3A inhibitor","Inhibitor","CYP3A43","cytochrome P450 family 3 subfamily A member 43",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04307693%22"
"MONDO_0100096","COVID-19","CHEMBL1431","METFORMIN","Small molecule","Mitochondrial complex I (NADH dehydrogenase) inhibitor","Inhibitor","MT-ND4L","mitochondrially encoded NADH:ubiquinone oxidoreductase core subunit 4L",2,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04604678%22"
"MONDO_0100096","COVID-19","CHEMBL1370","BUDESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",2,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04416399%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04590274%22"
"MONDO_0100096","COVID-19","CHEMBL1201670","SARGRAMOSTIM","Protein","Granulocyte-macrophage colony-stimulating factor receptor agonist","Agonist","CSF2RA","colony stimulating factor 2 receptor subunit alpha",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04690387%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP3","caspase 3",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL4297680","1018 ISS","Unknown","Toll-like receptor 9 agonist","Agonist","TLR9","toll like receptor 9",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04405908%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","Adenosine A2 receptor antagonist","Antagonist","ADORA2A","adenosine A2a receptor",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL192","SILDENAFIL","Small molecule","Phosphodiesterase 5A inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04489446%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6C","phosphodiesterase 6C",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL139","DICLOFENAC","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04900129%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",1,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04435808%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE9A","phosphodiesterase 9A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP10","caspase 10",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04581954%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04333654%22,https://clinicaltrials.gov/search?id=%22NCT04351620%22,https://clinicaltrials.gov/search?id=%22NCT04344457%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7A","phosphodiesterase 7A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE2A","phosphodiesterase 2A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",1,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04356677%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6A","phosphodiesterase 6A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE7B","phosphodiesterase 7B",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL190461","CANNABIDIOL","Small molecule","Cannabinoid CB1 receptor negative allosteric modulator","Negative allosteric modulator","CNR1","cannabinoid receptor 1",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04686539%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB","tubulin beta class I",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE10A","phosphodiesterase 10A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP8","caspase 8",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B1","guanylate cyclase 1 soluble subunit beta 1",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04383002%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Anandamide amidohydrolase inhibitor","Inhibitor","FAAH","fatty acid amide hydrolase",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04324606%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP2","caspase 2",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","D2-like dopamine receptor antagonist","Antagonist","DRD3","dopamine receptor D3",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354805%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1B","phosphodiesterase 1B",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL3545347","TXA127","Protein","Proto-oncogene Mas agonist","Agonist","MAS1","MAS1 proto-oncogene, G protein-coupled receptor",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04570501%22"
"MONDO_0100096","COVID-19","CHEMBL1034","DICLOFENAC SODIUM","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04900129%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B2","guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04383002%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARA","retinoic acid receptor alpha",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04730895%22,https://clinicaltrials.gov/search?id=%22NCT04382950%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04333654%22,https://clinicaltrials.gov/search?id=%22NCT04351620%22,https://clinicaltrials.gov/search?id=%22NCT04344457%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4A","tubulin beta 4A class IVa",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL6","INDOMETHACIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04344457%22"
"MONDO_0100096","COVID-19","CHEMBL34259","METHOTREXATE","Small molecule","Dihydrofolate reductase inhibitor","Inhibitor","DHFR","dihydrofolate reductase",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04352465%22"
"MONDO_0100096","COVID-19","CHEMBL3707348","ACALABRUTINIB","Small molecule","Tyrosine-protein kinase BTK inhibitor","Inhibitor","BTK","Bruton tyrosine kinase",1,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04497948%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL191","LOSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04335123%22"
"MONDO_0100096","COVID-19","CHEMBL256087","MENTHOL","Small molecule","Transient receptor potential cation channel subfamily A member 1 opener","Opener","TRPA1","transient receptor potential cation channel subfamily A member 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04900129%22"
"MONDO_0100096","COVID-19","CHEMBL1034","DICLOFENAC SODIUM","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04900129%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP12","caspase 12 (gene/pseudogene)",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Vanilloid receptor opener","Opener","TRPV1","transient receptor potential cation channel subfamily V member 1",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04324606%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6H","phosphodiesterase 6H",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1201187","MARAVIROC","Small molecule","C-C chemokine receptor type 5 antagonist","Antagonist","CCR5","C-C motif chemokine receptor 5",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04435522%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARG","retinoic acid receptor gamma",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04730895%22,https://clinicaltrials.gov/search?id=%22NCT04382950%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP7","caspase 7",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04461353%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",1,"Terminated","https://clinicaltrials.gov/search?id=%22NCT04435808%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 7 inhibitor","Inhibitor","MMP7","matrix metallopeptidase 7",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4B","phosphodiesterase 4B",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1C","phosphodiesterase 1C",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL3545189","LANADELUMAB","Antibody","Plasma kallikrein inhibitor","Inhibitor","KLKB1","kallikrein B1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04422509%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04497519%22,https://clinicaltrials.gov/search?id=%22NCT04461353%22"
"MONDO_0100096","COVID-19","CHEMBL2103830","FOSTAMATINIB","Small molecule","Tyrosine-protein kinase SYK inhibitor","Inhibitor","SYK","spleen associated tyrosine kinase",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04581954%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6D","phosphodiesterase 6D",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL160","CYCLOSPORINE","Protein","Cyclophilin A modulator","Modulator","PPIA","peptidylprolyl isomerase A",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04412785%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6B","phosphodiesterase 6B",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1370","BUDESONIDE","Small molecule","Glucocorticoid receptor agonist","Agonist","NR3C1","nuclear receptor subfamily 3 group C member 1",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04964414%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL6","INDOMETHACIN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04344457%22"
"MONDO_0100096","COVID-19","CHEMBL547","ISOTRETINOIN","Small molecule","Retinoic acid receptor agonist","Agonist","RARB","retinoic acid receptor beta",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04382950%22,https://clinicaltrials.gov/search?id=%22NCT04730895%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3A","phosphodiesterase 3A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB8","tubulin beta 8 class VIII",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL1200699","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 8 inhibitor","Inhibitor","MMP8","matrix metallopeptidase 8",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP14","caspase 14",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL409","BICALUTAMIDE","Small molecule","Androgen Receptor antagonist","Antagonist","AR","androgen receptor",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04652765%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE1A","phosphodiesterase 1A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8A","phosphodiesterase 8A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","Adenosine A2 receptor antagonist","Antagonist","ADORA2B","adenosine A2b receptor",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK2 inhibitor","Inhibitor","JAK2","Janus kinase 2",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04334044%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE5A","phosphodiesterase 5A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL256087","MENTHOL","Small molecule","Transient receptor potential cation channel subfamily M member 8 opener","Opener","TRPM8","transient receptor potential cation channel subfamily M member 8",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04900129%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase 13 inhibitor","Inhibitor","MMP13","matrix metallopeptidase 13",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B2","guanylate cyclase 1 soluble subunit beta 2 (pseudogene)",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04601077%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04581954%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP9","caspase 9",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP4","caspase 4",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB6","tubulin beta 6 class V",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04461353%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP6","caspase 6",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL1789941","RUXOLITINIB","Small molecule","Tyrosine-protein kinase JAK1 inhibitor","Inhibitor","JAK1","Janus kinase 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04334044%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04590274%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE8B","phosphodiesterase 8B",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1433","DOXYCYCLINE","Small molecule","Matrix metalloproteinase-1 inhibitor","Inhibitor","MMP1","matrix metallopeptidase 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04591600%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04497519%22,https://clinicaltrials.gov/search?id=%22NCT04461353%22"
"MONDO_0100096","COVID-19","CHEMBL960","LEFLUNOMIDE","Small molecule","Dihydroorotate dehydrogenase inhibitor","Inhibitor","DHODH","dihydroorotate dehydrogenase (quinone)",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04361214%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP1","caspase 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2B","tubulin beta 2B class IIb",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL139","DICLOFENAC","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04900129%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB2A","tubulin beta 2A class IIa",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL3545189","LANADELUMAB","Antibody","Plasma kallikrein inhibitor","Inhibitor","KLKB1","kallikrein B1",1,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04460105%22"
"MONDO_0100096","COVID-19","CHEMBL3137301","SACUBITRIL","Small molecule","Neprilysin inhibitor","Inhibitor","MME","membrane metalloendopeptidase",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04883528%22"
"MONDO_0100096","COVID-19","CHEMBL1201558","INTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04379518%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE6G","phosphodiesterase 6G",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL1200689","NITRIC OXIDE","Small molecule","Soluble guanylate cyclase activator","Activator","GUCY1B1","guanylate cyclase 1 soluble subunit beta 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04601077%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4D","phosphodiesterase 4D",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE3B","phosphodiesterase 3B",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS2","prostaglandin-endoperoxide synthase 2",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04324606%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","Serotonin 2a (5-HT2a) receptor antagonist","Antagonist","HTR2A","5-hydroxytryptamine receptor 2A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354805%22"
"MONDO_0100096","COVID-19","CHEMBL1643","RIBAVIRIN","Small molecule","Inosine-5'-monophosphate dehydrogenase 1 inhibitor","Inhibitor","IMPDH1","inosine monophosphate dehydrogenase 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04551768%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","D2-like dopamine receptor antagonist","Antagonist","DRD4","dopamine receptor D4",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354805%22"
"MONDO_0100096","COVID-19","CHEMBL413","SIROLIMUS","Small molecule","FK506-binding protein 1A inhibitor","Inhibitor","FKBP1A","FKBP prolyl isomerase 1A",1,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04482712%22,https://clinicaltrials.gov/search?id=%22NCT04371640%22"
"MONDO_0100096","COVID-19","CHEMBL902","FAMOTIDINE","Small molecule","Histamine H2 receptor antagonist","Antagonist","HRH2","histamine receptor H2",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04545008%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04355728%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB1","tubulin beta 1 class VI",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL160","CYCLOSPORINE","Protein","Cyclophilin A modulator","Modulator","PPIA","peptidylprolyl isomerase A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04540926%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04743011%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4A","phosphodiesterase 4A",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB3","tubulin beta 3 class III",1,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04762771%22"
"MONDO_0100096","COVID-19","CHEMBL190461","CANNABIDIOL","Small molecule","Cannabinoid CB1 receptor negative allosteric modulator","Negative allosteric modulator","CNR1","cannabinoid receptor 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04731116%22"
"MONDO_0100096","COVID-19","CHEMBL1069","VALSARTAN","Small molecule","Type-1 angiotensin II receptor antagonist","Antagonist","AGTR1","angiotensin II receptor type 1",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04883528%22"
"MONDO_0100096","COVID-19","CHEMBL628","PENTOXIFYLLINE","Small molecule","3',5'-cyclic phosphodiesterase inhibitor","Inhibitor","PDE4C","phosphodiesterase 4C",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04433988%22"
"MONDO_0100096","COVID-19","CHEMBL112","ACETAMINOPHEN","Small molecule","Cyclooxygenase inhibitor","Inhibitor","PTGS1","prostaglandin-endoperoxide synthase 1",1,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT04324606%22"
"MONDO_0100096","COVID-19","CHEMBL1201558","INTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04379518%22"
"MONDO_0100096","COVID-19","CHEMBL2107862","RINTATOLIMOD","Oligonucleotide","Toll-like receptor 3 agonist","Agonist","TLR3","toll like receptor 3",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04379518%22"
"MONDO_0100096","COVID-19","CHEMBL107","COLCHICINE","Small molecule","Tubulin inhibitor","Inhibitor","TUBB4B","tubulin beta 4B class IVb",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04392141%22"
"MONDO_0100096","COVID-19","CHEMBL71","CHLORPROMAZINE","Small molecule","D2-like dopamine receptor antagonist","Antagonist","DRD2","dopamine receptor D2",1,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04354805%22"
"MONDO_0100096","COVID-19","CHEMBL103","PROGESTERONE","Small molecule","Progesterone receptor agonist","Agonist","PGR","progesterone receptor",1,"Completed","https://clinicaltrials.gov/search?id=%22NCT04365127%22"
"MONDO_0100096","COVID-19","CHEMBL197672","EMRICASAN","Small molecule","Caspase inhibitor","Inhibitor","CASP5","caspase 5",1,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04803227%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",0,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04329572%22,https://clinicaltrials.gov/search?id=%22NCT04348474%22"
"MONDO_0100096","COVID-19","CHEMBL1201558","INTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR1","interferon alpha and beta receptor subunit 1",0,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04293887%22"
"MONDO_0100096","COVID-19","CHEMBL1201670","SARGRAMOSTIM","Protein","Granulocyte-macrophage colony-stimulating factor receptor agonist","Agonist","CSF2RA","colony stimulating factor 2 receptor subunit alpha",0,"Active, not recruiting","https://clinicaltrials.gov/search?id=%22NCT03348670%22,https://clinicaltrials.gov/search?id=%22NCT03305341%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",0,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04329572%22,https://clinicaltrials.gov/search?id=%22NCT04348474%22"
"MONDO_0100096","COVID-19","CHEMBL1690","HYDROXYCHLOROQUINE SULFATE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",0,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04329572%22,https://clinicaltrials.gov/search?id=%22NCT04348474%22"
"MONDO_0100096","COVID-19","CHEMBL41","FLUOXETINE","Small molecule","Serotonin transporter inhibitor","Inhibitor","SLC6A4","solute carrier family 6 member 4",0,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04570449%22"
"MONDO_0100096","COVID-19","CHEMBL2108730","SARILUMAB","Antibody","Interleukin-6 receptor alpha subunit antagonist","Antagonist","IL6R","interleukin 6 receptor",0,"Recruiting","https://clinicaltrials.gov/search?id=%22NCT04386239%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",0,"Suspended","https://clinicaltrials.gov/search?id=%22NCT04348474%22,https://clinicaltrials.gov/search?id=%22NCT04329572%22"
"MONDO_0100096","COVID-19","CHEMBL1201558","INTERFERON ALFA-2B","Protein","Interferon alpha/beta receptor agonist","Agonist","IFNAR2","interferon alpha and beta receptor subunit 2",0,"Not yet recruiting","https://clinicaltrials.gov/search?id=%22NCT04293887%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 7 antagonist","Antagonist","TLR7","toll like receptor 7",0,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04323631%22"
"MONDO_0100096","COVID-19","CHEMBL1201657","HEPARIN SODIUM","Oligosaccharide","Antithrombin-III activator","Activator","SERPINC1","serpin family C member 1",0,"Completed","https://clinicaltrials.gov/search?id=%22NCT04490239%22"
"MONDO_0100096","COVID-19","CHEMBL1535","HYDROXYCHLOROQUINE","Small molecule","Toll-like receptor 9 antagonist","Antagonist","TLR9","toll like receptor 9",0,"Withdrawn","https://clinicaltrials.gov/search?id=%22NCT04323631%22"